Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
873 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
002090-C
ComboMATCH Treatment Trial N5: Randomized Trial of Neratinib, a Pan-ErbB Inhibitor alone or in combination with Palbociclib, a CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and other Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
002073-M
Characterizing the Brain Circuitry and Neural Activity Mediating Frustration
Recruitment has not started
18-55 Years
NIMH
18
002056-C
Phase 1/1B Study of DS-8201a in Combination with ATR Inhibition (AZD6738) in Advanced Solid Tumors with HER2 Expression (DASH Trial)
Recruitment has not started
18-120 Years
NCI
18
002041-C
Phase 2 Trial of the Combination of the BET inhibitor, ZEN003694 (ZEN-3694), and the PARP Inhibitor Talazoparib, in Patients with Molecularly-Selected Solid Tumors (ComBET)
Recruitment has not started
18-120 Years
NCI
18
001979-I
A Pilot Phase 2 Study of the Safety and Efficacy of Dupilumab as Add-on Therapy for Hypereosinophilic Syndrome with Partial Clinical Response to Eosinophil-Depleting Biologic Agents
Recruitment has not started
18-99 Years
NIAID
18
001961-C
A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination with the ATR Inhibitor M1774
Participants currently recruited/enrolled
18-120 Years
NCI
18
001951-C
Natural History Study of Kaposi Sarcoma
Participants currently recruited/enrolled
18-120 Years
NCI
18
001925-N
Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort
Recruitment has not started
18-50 Years
NINDS
18
001924-C
A Phase 1, Open-Label, Dose Escalation Study of the Safety and Tolerability of ANK-101 in Advanced Solid Tumors
Recruitment has not started
18-120 Years
NCI
18
001920-C
A ComboMATCH Treatment Trial: FOLFOX In Combination With Binimetinib As 2nd Line Therapy For Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations
Participants currently recruited/enrolled
18-120 Years
NCI
18
001899-I
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Participants currently recruited/enrolled
18-120 Years
NIAID
18
001886-C
A Phase 1 Study of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
Participants currently recruited/enrolled
18-120 Years
NCI
18
001883-H
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
001874-M
Natural History of Depression, Bipolar Disorder and Suicide Risk
Recruitment has not started
18-120 Years
NIMH
18
001859-C
A Phase I Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Recruitment has not started
18-120 Years
NCI
18
001854-I
An Open-Label Study of Zemaira (Alpha 1-Trypsin Inhibitor) in Subjects with Eosinophilic Esophagitis
Participants currently recruited/enrolled
18-70 Years
NIAID
18
001833-D
Sjogren's Team for Accelerating Medicines Partnership (STAMP)
Participants currently recruited/enrolled
18-79 Years
NIDCR
18
001827-C
Phase 3, Multicenter, Randomized, Open-Label Study to Assess the Efficacy and Safety Of the Lifileucel (LN-144), Autologous Tumor-Infiltrating Lymphocytes [TIL]) Regimen in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy in Partici
Recruitment has not started
18-70 Years
NCI
18
001826-C
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems using Pupillometry in Participants with Neurofibromatosis Type 1 (NF1)
Recruitment has not started
1-120 Years
NCI
18
001784-C
Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
Recruitment has not started
18-120 Years
NCI
18
001783-C
An Open-label, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of CRG-022, a CD22-Directed Autologous Chimeric Antigen Receptor (CAR) T-cell Therapy in Participants With Relapsed/Refractory Large B-Cell Lymphoma After CD19-Directed CAR T-cel
Participants currently recruited/enrolled
18-120 Years
NCI
18
001778-C
A Randomized, Open Label, Two-Arm, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of PRGN-2009 in Combination with Pembrolizumab Versus Pembrolizumab Monotherapy in Patients with Recurrent or Metastatic Cervical Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
001776-C
A Phase 1 Dose Escalation and Expansion Study of GIGA-564, a Minimally Blocking Anti-CTLA-4 Monoclonal Antibody, in Participants with Locally Advanced or Metastatic Solid Tumor Malignancies
Participants currently recruited/enrolled
18-120 Years
NCI
18
001770-C
Molecular Analysis for Combination Therapy Choice (ComboMATCH) EAY191-N4: A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers
Participants currently recruited/enrolled
18-120 Years
NCI
18
001756-C
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin in Patients with Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
Participants currently recruited/enrolled
18-120 Years
NCI
18
001749-C
ComboMATCH Treatment Trial E4: Nilotinib and Paclitaxel in Patients with Prior Taxane-Treated Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
001746-DK
Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation
Recruitment has not started
18-50 Years
NIDDK
18
001733-C
A Phase 1 Clinical Trial of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Metastatic or Unresectable Pancreatic Ductal Carcinoma
Participants currently recruited/enrolled
18-100 Years
NCI
18
001732-C
A Phase 1 Study of the Polymerase Theta (POL-Theta) Inhibitor Novobiocin in BRCA-mutant and Other DNA Damage Repair-Deficient Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
001731-C
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Recruitment has not started
18-120 Years
NCI
18
001730-C
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination with Immunotherapy Vaccine PRGN-2009 in Subjects with Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
001722-I
An Open-label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 1 to 6 Years) with APDS (Activated Phosphoinositide 3-Kinase Delta Syndrome) Followed by an Open-label Long-term Ext
Participants currently recruited/enrolled
3-6 Years
NIAID
18
001713-C
A Phase II Trial of Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
001711-C
Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) with Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Parag
Recruitment has not started
18-120 Years
NCI
18
001709-C
Phase I Trial of [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Recruitment has not started
18-120 Years
NCI
18
001707-DK
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
Participants currently recruited/enrolled
18-99 Years
NIDDK
18
001704-C
Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients with Soft Tissue Sarcoma
Clinical hold/Recruitment or enrollment suspended
18-100 Years
NCI
18
001700-AR
A Randomized, Double-Blind, Placebo-Controlled, Phase Ib Study to Evaluate the Safety, Tolerability, And Pharmacokinetics of Gusacitinib in Subjects with Systemic Lupus Erythematosus (SLE)
Recruitment has not started
18-99 Years
NIAMS
18
001695-C
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNS-101 (anti-VISTA) as Monotherapy and in Combination with Cemiplimab in Patients with Advanced Solid Tumors
Recruitment has not started
18-120 Years
NCI
18
001691-C
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants with Primary Colorectal or Gastroesophageal Cancer
Recruitment has not started
18-120 Years
NCI
18
001690-DK
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
Participants currently recruited/enrolled
18-65 Years
NIDDK
18
001678-AT
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals with Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
Recruitment has not started
18-100 Years
NCCIH
18
001667-H
A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed / Refractory Immune Bone Marrow Failure
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
001665-C
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
Participants currently recruited/enrolled
2-120 Years
NCI
18
001662-C
A Phase Ib Clinical Trial to Evaluate the Administration of Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction with a Vaccine Directed Against these Antigens in Participants with Metastatic Cance
Participants currently recruited/enrolled
18-72 Years
NCI
18
001651-DK
A Pilot Study to Assess Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
Participants currently recruited/enrolled
18-65 Years
NIDDK
18
001642-N
ALLFTD: ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration
Participants currently recruited/enrolled
18-99 Years
NINDS
18
001636-CC
A Pilot Study of a Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Participants currently recruited/enrolled
18-100 Years
CC
18
001631-I
An Exploratory Study of The Effect of Bismuth Subsalicylate on The Gut Microbiome and Host Response in Healthy Adults
Participants currently recruited/enrolled
18-50 Years
NIAID
18
001620-C
Pilot Prospective Study for PET-CT Imaging in Participants with Relapsed/Refractory Acute Leukemias
Participants currently recruited/enrolled
5-39 Years
NCI
18
001619-H
A Phase I Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with Stable Sickle Cell Disease
Recruitment has not started
18-65 Years
NHLBI
18
001614-I
VRC 326 (001614): A Phase I Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
Participants currently recruited/enrolled
18-50 Years
NIAID
18
001606-DK
A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Recruitment has not started
18-65 Years
NIDDK
18
001603-DA
Semaglutide Therapy for Alcohol Reduction (STAR): A Proof-of-Concept Phase II Clinical Trial
Participants currently recruited/enrolled
18-110 Years
NIDA
18
001602-M
An Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Recruitment has not started
18-70 Years
NIMH
18
001601-C
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Recruitment has not started
18-120 Years
NCI
18
001600-C
Phase 2 Study Evaluating the Functional Status of the Adrenal Glands with [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
Participants currently recruited/enrolled
18-120 Years
NCI
18
001599-C
Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
Recruitment has not started
18-120 Years
NCI
18
001591-C
Pilot Study of CBX-12 Pharmacodynamics in Patients with Advanced Solid Tumors
Participants currently recruited/enrolled
18-100 Years
NCI
18
001590-C
Rapid Analysis and Response Evaluation of Combination Anti-neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 3 Tiragolumab + Atezolizumab
Participants currently recruited/enrolled
18-100 Years
NCI
18
001582-C
Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer Patients
Recruitment has not started
18-120 Years
NCI
18
001580-I
Phase 1/2 Trial of Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-linked Chronic Granulomatous Disease
Participants currently recruited/enrolled
18-75 Years
NIAID
18
001577-E
Phase IIa Investigation of H01 in Adults with Interstitial Lung Disease (The SOLIS Study)
Recruitment has not started
18-100 Years
NIEHS
18
001573-I
An Open-Label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 4 to 11 Years) With APDS (Activated Phosphoinositide 3-Kinase Delta Syndrome) Followed by an Open-Label Long-Term Ex
No longer recruiting/follow-up only
4-11 Years
NIAID
18
001572-C
A Phase II Study of Bevacizumab in Adults with Recurrent Respiratory Papillomatosis (RRP)
Participants currently recruited/enrolled
18-120 Years
NCI
18
001569-C
A Phase I Study to Investigate the Safety of the Ubiquitin Activating Enzyme Inhibitor TAK-243 in Adult Solid Tumor and Lymphoma Patients
Recruitment has not started
18-100 Years
NCI
18
001564-C
A Phase II Sequential Window of Opportunity Trial of Pembrolizumab + N-803 alone or in Combination with PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
Recruitment has not started
18-120 Years
NCI
18
001563-C
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
Participants currently recruited/enrolled
18-120 Years
NCI
18
001561-AA
Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
Recruitment has not started
18-75 Years
NIAAA
18
001560-DC
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Participants currently recruited/enrolled
3-99 Years
NIDCD
18
001559-C
A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Recruitment has not started
18-120 Years
NCI
18
001557-C
Phase I/II Trial of Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination with HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants with Advanced or Metastatic Endometrial Cancer (EC)
Participants currently recruited/enrolled
18-120 Years
NCI
18
001556-C
Phase II Trial of Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) without Testosterone Lowering Therapy
Participants currently recruited/enrolled
18-120 Years
NCI
18
001554-C
Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Recruitment has not started
12-120 Years
NCI
18
001552-C
Phase II Study of Enasidenib in IDH2-mutated Malignant Sinonasal and Skull Base Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
001548-C
A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination with Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects with Biliary Tract Carcinoma (BTC)
Participants currently recruited/enrolled
0-120 Years
NCI
18
001547-C
A First-in-Human Phase I Trial with Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
Participants currently recruited/enrolled
18-120 Years
NCI
18
001545-C
A Phase Ib/II Multicenter Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
Recruitment has not started
18-120 Years
NCI
18
001542-C
Phase Ib Study of Imatinib to Increase RUNX1 Activity in Participants with Germline RUNX1 Deficiency
Participants currently recruited/enrolled
18-120 Years
NCI
18
001541-C
A Phase I/II Trial of Eltanexor (KPT-8602) with Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
Participants currently recruited/enrolled
18-120 Years
NCI
18
001538-C
A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma and Multicentric Castleman Disease
Participants currently recruited/enrolled
18-120 Years
NCI
18
001537-C
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
Recruitment has not started
18-120 Years
NCI
18
001536-C
Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 with Pembrolizumab before Standard Treatment in Subjects with Newly Diagnosed HPV-Associated Oropharyngeal Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
001535-C
A Phase II Study of Sacituzumab Govitecan with or without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer
Recruitment has not started
18-120 Years
NCI
18
001534-C
Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors containing MYC or MYCN Amplifications
Participants currently recruited/enrolled
18-120 Years
NCI
18
001533-C
A Phase II Multicenter Study of Enfortumab Vedotin with or without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Recruitment has not started
18-120 Years
NCI
18
001528-H
A Phase I/II, Intra-Patient Dose-Escalation Study of the Selective GlyT1 Inhibitor, Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia.
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
001525-C
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
Participants currently recruited/enrolled
18-120 Years
NCI
18
001524-C
A Phase I Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T- Cells for Treating B-cell Malignancies
Participants currently recruited/enrolled
18-75 Years
NCI
18
001523-C
A Phase II Study of Lurbinectedin with or without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Participants currently recruited/enrolled
18-120 Years
NCI
18
001522-H
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous ZMA001 in Healthy Subjects
Participants currently recruited/enrolled
18-60 Years
NHLBI
18
001521-D
CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Participants currently recruited/enrolled
16-99 Years
NIDCR
18
001519-N
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy: A Pilot Study
Participants currently recruited/enrolled
18-120 Years
NINDS
18
001516-C
Phase I Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
001509-I
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections
Participants currently recruited/enrolled
18-100 Years
NIAID
18
001505-N
A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, First In-Patient Study of AJ201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Spinal and Bulbar Muscular Atrophy (SBMA)
Participants currently recruited/enrolled
18-120 Years
NINDS
18
001501-I
Phase 1 Dose Escalation Study of The Plasmodium Vivax Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-Blocking Activity in Healthy Malaria-Naive Adults
Participants currently recruited/enrolled
18-50 Years
NIAID
18
001156-DA
Development and Validation of Learning and Decision-Making Tasks
Participants currently recruited/enrolled
18-45 Years
NIDA
18
001125-DK
Optimizing HBV Care Cascade among Foreign-Born in the United States (FOCUS-HBV Study)
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
001099-C
A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-Fusion Molecule, in Subjects with Unresectable, Locally Advanced, or Metastatic Solid Tumors that
Participants currently recruited/enrolled
18-125 Years
NCI
18
001085-D
Phase 2 Study of the PTH-Independent Effects of Encaleret on Mineral Homeostasis in Subjects with Post-Surgical Hypoparathyroidism (PSH)
Participants currently recruited/enrolled
18-100 Years
NIDCR
18
001078-I
Phase 1 Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
Participants currently recruited/enrolled
18-59 Years
NIAID
18
001073-E
NIEHS Repository of Stored Biological Samples for Future Use
Participants currently recruited/enrolled
18-100 Years
NIEHS
18
001066-DA
Orexin's Role in The Neurobiology of Substance Use Disorder
Participants currently recruited/enrolled
18-60 Years
NIDA
18
001058-DK
A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)
Participants currently recruited/enrolled
18-75 Years
NIDDK
18
001056-C
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Participants currently recruited/enrolled
18-120 Years
NCI
18
001048-I
A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative Persons
Participants currently recruited/enrolled
18-25 Years
NIAID
18
001037-I
A Randomized Placebo-controlled Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living with HIV and on Suppressive Antiretroviral Therapy
Participants currently recruited/enrolled
18-70 Years
NIAID
18
001004-C
A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon Oncosignature(R) Status
Participants currently recruited/enrolled
18-120 Years
NCI
18
000978-M
State-Dependent Interoception, Value-Based Decision Making, and Introspection
Participants currently recruited/enrolled
18-55 Years
NIMH
18
000975-C
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples from Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
18
000958-C
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by Invitation
18-125 Years
NCI
18
000954-C
A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients with Advanced Mesothelin-Expressing Cancer
No longer recruiting/follow-up only
18-120 Years
NCI
18
000930-C
A Phase 1b/2 Study of HCW9218, a Bifunctional TGF-beta Antagonist/IL-15 Protein Complex, for Advanced Pancreatic Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
000923-H
Observational Study of Cardiac Arrhythmias During Treatment with BTK Inhibitors or Venetoclax
Participants currently recruited/enrolled
18-110 Years
NHLBI
18
000922-DA
Defining Neurobiological Links between Substance Use and Mental Illness
Participants currently recruited/enrolled
18-60 Years
NIDA
18
000911-DK
Dinner Time for Obesity and Prediabetes (DTOP)
Participants currently recruited/enrolled
18-50 Years
NIDDK
18
000910-DA
Real-world Momentary Assessment of Kratom use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom use and Pharmacology
Completed Study; data analyses ongoing
18-125 Years
NIDA
18
000906-I
A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy Volunteers
Recruitment has not started
18-55 Years
NIAID
18
000894-AR
Natural History of Inflammatory Muscle Diseases
Participants currently recruited/enrolled
12-120 Years
NIAMS
18
000889-I
VRC 615: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB-0115-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults
No longer recruiting/follow-up only
18-60 Years
NIAID
18
000871-CC
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults
Participants currently recruited/enrolled
18-60 Years
CC
18
000869-DK
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
Participants currently recruited/enrolled
18-60 Years
NIDDK
18
000866-I
Phase 1/2 Open-label Trial of Safety and Zoster Immunogenicity Evaluation for people with HIV with CD4 counts Under and Above 300 following Shingrix Vaccination and Healthy Volunteers (ZEUS)
Participants currently recruited/enrolled
18-125 Years
NIAID
18
000860-C
A Phase I/II Study of Zotiraciclib for Recurrent High-Grade Gliomas with Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Participants currently recruited/enrolled
18-125 Years
NCI
18
000849-CH
Speckle Plethysmography Pulse Transit Time as a Marker of Blood Pressure Changes
Participants currently recruited/enrolled
18-99 Years
NICHD
18
000844-H
Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients with Sickle Cell Disease (SCD)
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
000829-H
Controls and Healthy Vasculature Initiative
Participants currently recruited/enrolled
18-125 Years
NHLBI
18
000824-M
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
Completed Study; data analyses ongoing
18-70 Years
NIMH
18
000821-I
An Open-Label, Single-Arm, Phase 1/2 Dose-Escalation Trial of Long-Acting Recombinant Human IL-7 (NT-I7, Efineptakin-Alpha) for Idiopathic CD4 Lymphopenia
Recruitment has not started
18-75 Years
NIAID
18
000784-N
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
Participants currently recruited/enrolled
18-100 Years
NINDS
18
000781-I
A Phase III, Adjudicator-Blinded, Randomised Study to Evaluate the Efficacy and Safety of Treatment with Olorofim Versus Treatment with AmBisome(R) Followed by Standard of Care (SOC) in Patients with Invasive Fungal Disease (IFD) Caused by Aspergillus Sp
Participants currently recruited/enrolled
18-125 Years
NIAID
18
000776-M
An Open Trial of Transcranial Magnetic Stimulation for Youth with Treatment-Resistant Major Depressive Disorder
Participants currently recruited/enrolled
13-17 Years
NIMH
18
000767-CC
Phase I Open Label Clinical Trial Using Resiniferatoxin, A Non-Opioid Medication, For the Management of Refractory Morton's Neuroma Pain
Participants currently recruited/enrolled
18-125 Years
CC
18
000758-H
A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias
Participants currently recruited/enrolled
18-75 Years
NHLBI
18
000757-DK
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects with Lipodystrophy
Participants currently recruited/enrolled
0-98 Years
NIDDK
18
000756-DK
Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance
Participants currently recruited/enrolled
18-65 Years
NIDDK
18
000731-C
A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients with Acute Myeloid Leukemia who are at High-Risk for Leukemia Relapse following Hematopoietic Cell Transplantation
Participants currently recruited/enrolled
18-70 Years
NCI
18
000726-C
A Randomized Phase 2 Study of Atezolizumab with or without Selinexor in Alveolar Soft Part Sarcoma (AXIOM)
Participants currently recruited/enrolled
18-125 Years
NCI
18
000711-N
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC)
Enrolling by Invitation
18-100 Years
NINDS
18
000696-C
A Phase III, Multicenter, International Study with a Parallel, Randomized, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants with NF1 who have Symptomatic, Inoperable Plexiform Neurofibr
No longer recruiting/follow-up only
18-120 Years
NCI
18
000688-I
Longitudinal Observations of Vaccine Responses to SARS-CoV-2 and other Emerging Infectious Diseases
Participants currently recruited/enrolled
18-125 Years
NIAID
18
000687-I
VRC 322/DMID 21-0016: A Phase I, Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults
No longer recruiting/follow-up only
18-60 Years
NIAID
18
000682-AR
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus
Participants currently recruited/enrolled
18-80 Years
NIAMS
18
000676-M
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
Participants currently recruited/enrolled
18-70 Years
NIMH
18
000674-M
Assessment of [18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects
Completed Study; data analyses ongoing
18-99 Years
NIMH
18
000666-C
A Phase I/II Study of Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Participants currently recruited/enrolled
18-100 Years
NCI
18
000665-DK
A Randomized Double-Blind Placebo-Controlled Study of the LEPR Agonist Antibody REGN4461 for the Treatment of Metabolic Abnormalities in Patients with Familial Partial Lipodystrophy
Completed Study; data analyses ongoing
18-90 Years
NIDDK
18
000657-C
Acceptance and Commitment Therapy for Caregivers of Children with a RASopathy: An Internal Pilot Feasibility Study and Follow-up Phase III Randomized Controlled Trial
Participants currently recruited/enrolled
18-125 Years
NCI
18
000647-C
An Open-label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Bintrafusp alfa (M7824) Clinical Studies
Recruitment has not started
18-120 Years
NCI
18
000643-C
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Participants currently recruited/enrolled
18-125 Years
NCI
18
000642-N
Phase II Trial of Non-Invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
Participants currently recruited/enrolled
18-80 Years
NINDS
18
000633-C
Phase 1/2 Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
18
000628-C
A Study of Prospective Monitoring of Subjects with Biochemically Recurrent Prostate Cancer Using 18F-DCFPyL
Participants currently recruited/enrolled
18-125 Years
NCI
18
000625-N
Investigational use of Neuromuscular Ultrasound
Participants currently recruited/enrolled
18-110 Years
NINDS
18
000613-C
Phase I/II Trial to Determine the Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination with Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis after Reduced Intensity Conditioning and Peripheral Blood St
Participants currently recruited/enrolled
12-125 Years
NCI
18
000611-C
A Phase II Trial of Focal Ultrahypofractionated Stereotactic Radiation Therapy for the Treatment of Unifocal Prostate Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
000596-C
Phase II Study of Olaparib in Subjects with Advanced Pancreatic Acinar Cell Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000580-C
A Phase 1/2, Open Label Dose-Escalation and Expansion Trial of Nkt2152, an Orally Administered Hif2(alpha) Inhibitor, to Investigate Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity in Patients with Advanced Clear Cell Renal Cell Carcinom
Participants currently recruited/enrolled
18-125 Years
NCI
18
000569-C
Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy
Participants currently recruited/enrolled
18-125 Years
NCI
18
000560-N
Data Collection of Standard Care of Patients in the EMG Section
Participants currently recruited/enrolled
18-110 Years
NINDS
18
000556-H
NHLBI-Emory Advanced Cardiac CT Reconstruction
Recruitment has not started
18-100 Years
NHLBI
18
000545-DK
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant: A Prospective Natural History Study
Recruitment has not started
3-125 Years
NIDDK
18
000527-M
CNS Correlates of Extended Sleep Restriction
Participants currently recruited/enrolled
18-39 Years
NIMH
18
000520-C
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG with or without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NCI
18
000518-CC
Observational Study of Dietary Intake and Dietary Behaviors in Adults with Sickle Cell Disease
Participants currently recruited/enrolled
18-120 Years
CC
18
000516-C
Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma involving the Central Nervous System
No longer recruiting/follow-up only
18-125 Years
NCI
18
000494-DK
Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
000491-C
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Participants currently recruited/enrolled
18-125 Years
NCI
18
000489-C
Phase I/II Study Using Prophylactic Donor Lymphocyte Infusion Early Post-Transplant After Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for High-Risk Hematologic Malignancies
Participants currently recruited/enrolled
12-120 Years
NCI
18
000484-C
Randomized Phase II Trial of Durvalumab (D) plus Olaparib (O) and Cediranib (C: DOC) Compared to OC or DC or Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer with Prior Bevacizumab
No longer recruiting/follow-up only
18-125 Years
NCI
18
000483-M
PET Imaging of Cyclooxygenases in Multiple Sclerosis
Completed Study; data analyses ongoing
18-99 Years
NIMH
18
000481-C
Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
Participants currently recruited/enrolled
18-125 Years
NCI
18
000479-H
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
000478-C
A Phase I/II Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by GVHD Prophylaxis with Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living with HIV (PLWH)
Clinical hold/Recruitment or enrollment suspended
12-120 Years
NCI
18
000475-C
Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients with Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-deficient Gastrointestinal Stromal Tumor (GIST)
Participants currently recruited/enrolled
18-125 Years
NCI
18
000473-C
A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000462-C
Phase 2, Open-label, Single-arm, Window of Opportunity Study of ASP-1929 Photoimmunotherapy with Fluorescence Imaging in Patients With Operable Primary or Recurrent Head and Neck or Cutaneous Squamous Cell Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000444-H
Vaccine Responses in Patients with B Cell Malignancies
Participants currently recruited/enrolled
18-90 Years
NHLBI
18
000441-E
Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
Participants currently recruited/enrolled
18-100 Years
NIEHS
18
000428-N
An Observational Study to Assess Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Participants currently recruited/enrolled
18-120 Years
NINDS
18
000423-C
Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults with Sickle Cell Disease (SCD): A Pilot Randomized Controlled Trial
Participants currently recruited/enrolled
18-55 Years
NCI
18
000421-AA
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
Participants currently recruited/enrolled
18-65 Years
NIAAA
18
000413-H
Natural History study of CADASIL
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
000410-I
VRC 325 (000410): A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of Mosaic Quadrivalent Influenza Vaccine with and without Adjuplex Compared with a Licensed Inactivated Seasonal QIV, In Healthy Adults
Completed Study; data analyses ongoing
18-50 Years
NIAID
18
000406-AA
Addictions Neuroclinical Assessment
Enrolling by Invitation
18-99 Years
NIAAA
18
000404-C
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Clinical hold/Recruitment or enrollment suspended
18-75 Years
NCI
18
000392-I
Metabolic Profiling of Immune Responses in Immune-Mediated Diseases
Participants currently recruited/enrolled
18-75 Years
NIAID
18
000378-M
Identifying Decision Making Parameters in Healthy Volunteers (HV) and Anxiety Patients (AD)
Completed Study; data analyses ongoing
18-50 Years
NIMH
18
000359-C
Phase I/II study to reduce post-transplantation cyclophosphamide dosing for older or unfit patients undergoing bone marrow transplantation for hematologic malignancies
Participants currently recruited/enrolled
12-85 Years
NCI
18
000356-C
A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
Completed Study; data analyses ongoing
18-125 Years
NCI
18
000354-C
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000337-C
Natural History Study of KSHV-Associated Multicentric Castleman's Disease
Participants currently recruited/enrolled
18-125 Years
NCI
18
000331-I
Investigating the Human Immune Response to Ixodes scapularis Tick Bites
Participants currently recruited/enrolled
18-99 Years
NIAID
18
000328-C
Bicalutamide Implants (Biolen ) with Radiation Therapy in Patients with Localized Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
000326-H
A Phase 1, Dose Escalation, Safety and Tolerability Study of NX- 2127, a Bruton's Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies
Participants currently recruited/enrolled
18-125 Years
NHLBI
18
000320-I
Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
Completed Study; data analyses ongoing
18-55 Years
NIAID
18
000317-C
A Phase II, Open-Label Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma
Participants currently recruited/enrolled
18-120 Years
NCI
18
000315-MD
A Prospective Natural History Study of COVID-19 Using Digital Wearables
Completed Study; data analyses ongoing
18-65 Years
NIMHD
18
000310-CH
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human
Participants currently recruited/enrolled
18-99 Years
NICHD
18
000307-C
Phase II Study Evaluating the Efficacy of M9241 in Combination with Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects with Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000305-C
Exploratory Phase II Study of LAnreotide in Unresectable or Metastatic Pheochromocytoma / PARAganglioma
No longer recruiting/follow-up only
18-125 Years
NCI
18
000303-C
A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide Vs. Temozolomide and Olaparib For Advanced Pheochromocytoma And Paraganglioma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000302-C
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
18
000299-H
Technical Development of Cardiovascular MRI
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
000297-CH
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
No longer recruiting/follow-up only
18-99 Years
NICHD
18
000293-C
Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed with a Primary Central Nervous System Tumor
Completed Study; data analyses ongoing
18-125 Years
NCI
18
000281-I
Pilot Assessment To Find Evidence of Gastric Motility Abnormalities in Eosinophilic Gastric Disorders
Participants currently recruited/enrolled
18-59 Years
NIAID
18
000277-C
Imaging and Biopsy of People with HIV-1 Undergoing Analytic Treatment Interruption
Participants currently recruited/enrolled
18-100 Years
NCI
18
000274-C
Phase I Trial of Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NCI
18
000264-C
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
Participants currently recruited/enrolled
18-120 Years
NCI
18
000261-AA
Mechanisms Underlying Individual Variations of Taste and Smell in Obesity
Participants currently recruited/enrolled
18-65 Years
NIAAA
18
000256-I
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults after Vaccination
Participants currently recruited/enrolled
18-120 Years
NIAID
18
000254-C
A Phase II Trial of the Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
Participants currently recruited/enrolled
18-125 Years
NCI
18
000251-C
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
Participants currently recruited/enrolled
18-120 Years
NCI
18
000247-DK
Evaluation of Patients with Gastrointestinal Disease
Participants currently recruited/enrolled
18-120 Years
NIDDK
18
000237-C
Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis from Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
000236-I
A Phase 1 Study of Empagliflozin as Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
Participants currently recruited/enrolled
18-85 Years
NIAID
18
000226-I
Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy
Clinical hold/Recruitment or enrollment suspended
18-75 Years
NIAID
18
000220-DK
Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men with Obesity
Recruitment has not started
18-65 Years
NIDDK
18
000212-I
Induced Blood-Stage Plasmodium Vivax Infection with HMPBS02-Pv Challenge Agent in Healthy Malaria-Naive Adults to Produce a Plasmodium Vivax Parasite Cell Bank for Future Studies
Completed Study; data analyses ongoing
18-50 Years
NIAID
18
000207-AR
The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study
Participants currently recruited/enrolled
15-125 Years
NIAMS
18
000196-N
Task-dependent Effects of TMS on the Neural Biomarkers of Episodic Memory
Completed Study; data analyses ongoing
18-40 Years
NINDS
18
000194-C
A Phase I Trial of ProAgio, an anti- alpha-v-beta3 Integrin Cytotoxin, for Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Participants currently recruited/enrolled
18-120 Years
NCI
18
000193-C
Phase 1 Study of Copanlisib with Dose-adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and other High-Grade B-cell Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
18
000178-C
Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19
Participants currently recruited/enrolled
18-120 Years
NCI
18
000176-C
A Phase I/II Trial of Lurbinectedin with Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High Grade Neuroendocrine Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
000172-DK
The Impact of the Food Environment and Psychosocial Stress from the COVID-19 Pandemic on Eating Behavior and Weight Change
No longer recruiting/follow-up only
18-99 Years
NIDDK
18
000152-E
Natural History of The Human Biological Response to Environmental Exposure and Injury
Participants currently recruited/enrolled
18-125 Years
NIEHS
18
000149-H
Pilot Study to Explore the Anti-Inflammatory Effects of Time-Restricted Feeding
Completed Study; data analyses ongoing
18-80 Years
NHLBI
18
000144-C
A Phase I/II Study of Sacituzumab Govitecan plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NCI
18
000141-DC
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
Participants currently recruited/enrolled
18-80 Years
NIDCD
18
000137-CH
Implications of Maternal 45,X Mosaicism As A Secondary Genomic Finding Following Cell-free DNA Sequencing During Pregnancy: A Deep Phenotype Study
Recruitment has not started
18-99 Years
NICHD
18
000130-DK
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Participants currently recruited/enrolled
18-90 Years
NIDDK
18
000126-N
A Pilot Study of NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients with Progressive Multifocal Leukoencephalopathy
Participants currently recruited/enrolled
18-120 Years
NINDS
18
000118-DK
Prospective Cohort Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects with Chronic Liver Disease
No longer recruiting/follow-up only
18-100 Years
NIDDK
18
000115-C
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants with Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants with Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Booster D
Completed Study; data analyses ongoing
18-125 Years
NCI
18
000114-C
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination with the Immunocytokine M9241 in Localized High and Intermediate Risk Prostate Cancer Treated with Androgen Deprivation Therapy
Participants currently recruited/enrolled
18-125 Years
NCI
18
000110-H
A Phase II Study Evaluating Fostamatinib for Hospitalized Adults with COVID-19
Completed Study; data analyses ongoing
18-125 Years
NHLBI
18
000103-C
A Randomized Study Investigating the Pharmacokinetics of Standard Interval Dosing Compared to Extended Interval Dosing of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
000102-CC
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial
Participants currently recruited/enrolled
18-80 Years
CC
18
000101-M
An Investigation of the Antidepressant Effects of the mGlu2/3 receptor antagonist TS-161 in Treatment-Resistant Depression
Completed Study; data analyses ongoing
18-65 Years
NIMH
18
000096-C
A Phase II study of Immunotherapy Combination: Irradiated PD-L1 CAR-NK cells plus Pembrolizumab plus N-803 for Subjects with Recurrent/Metastatic Gastric or Head and Neck Cancer
Participants currently recruited/enrolled
18-120 Years
NCI
18
000094-N
An Observational Study of Neurologic Function After COVID -19 Infection
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
000092-C
Phase 1/2 study of Vincristine and Temozolomide in Combination with PEN-866 for Adolescents and Young Adults with Relapsed or Refractory Solid Tumors
Recruitment has not started
12-39 Years
NCI
18
000089-N
Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
Participants currently recruited/enrolled
18-100 Years
NINDS
18
000085-C
Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients: An Observational Study
Enrolling by Invitation
18-99 Years
NCI
18
000080-C
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
000079-DK
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Participants currently recruited/enrolled
18-98 Years
NIDDK
18
000064-I
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease with Inflammatory Complications
Enrolling by Invitation
18-99 Years
NIAID
18
000059-C
Phase I Study of Intratumor Injection of anti-Mesothelin Immunotoxin LMB-100 with Ipilimumab in Malignant Mesothelioma
Completed Study; data analyses ongoing
18-120 Years
NCI
18
000049-H
Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects with Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
No longer recruiting/follow-up only
18-70 Years
NHLBI
18
000048-C
A Multi-Center Natural History Study of Precision-Based Genomics in Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
000045-C
A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and other KK-LC-1 Positive Epithelial Cancers
Participants currently recruited/enrolled
18-120 Years
NCI
18
000043-DK
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
Participants currently recruited/enrolled
18-65 Years
NIDDK
18
000030-C
Phase 2 Study of Bintrafusp alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
No longer recruiting/follow-up only
18-125 Years
NCI
18
22-I-0008
A Single Arm Open Label Phase 2 Trial of Anti-CD4 Antibody UB-421 in Combination with Optimized Background Antiretroviral Therapy in Patients with Multi-Drug Resistant HIV-1 Infection
Participants currently recruited/enrolled
18-125 Years
NIAID
18
22-I-0001
NADPH Oxidase Correction in mRNA transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Participants currently recruited/enrolled
18-75 Years
NIAID
18
22-DK-0002
Effect of Ultra-processed versus Unprocessed Diets on Energy Metabolism
Participants currently recruited/enrolled
18-60 Years
NIDDK
18
22-C-0005
Phase I Dose Escalation and Expansion Study of Tazemetostat in Combination with Topotecan and Pembrolizumab in Recurrent Small Cell Lung Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
22-C-0003
Feasibility of Evaluating Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
Participants currently recruited/enrolled
18-39 Years
NCI
18
21-N-0016
Phase I/II Study of Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Participants currently recruited/enrolled
18-120 Years
NINDS
18
21-N-0010
A Phase 2 Clinical Trial of Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
No longer recruiting/follow-up only
18-120 Years
NINDS
18
21-M-0018
Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array
Participants currently recruited/enrolled
18-65 Years
NIMH
18
21-I-0005
Phase 1 Study of the Safety and Immunogenicity of an Epstein-Barr virus (EBV) gp350- Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
No longer recruiting/follow-up only
18-29 Years
NIAID
18
21-HG-0020
Caregiving Networks Across Disease Context and the Life Course: A Comparative Longitudinal Study
Participants currently recruited/enrolled
18-100 Years
NHGRI
18
21-H-0027
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens into the Human Lung
Participants currently recruited/enrolled
18-64 Years
NHLBI
18
21-DC-0002
Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer
Participants currently recruited/enrolled
18-100 Years
NIDCD
18
21-CH-0028
A Pilot Study to Evaluate A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
Clinical hold/Recruitment or enrollment suspended
18-78 Years
NICHD
18
21-C-0030
Phase I Study of GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0026
A Phase I/II Study of Abemaciclib in Patients with HIV-associated and HIV-negative Kaposi Sarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0024
A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients with High-Risk Smoldering Multiple Myeloma
No longer recruiting/follow-up only
18-125 Years
NCI
18
21-C-0023
A Phase I Study of Pomalidomide and Nivolumab in Patients with Virus-Associated Malignancies with or without HIV
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0021
SARC037: A Phase I Study to Evaluate the Safety of Trabectedin Administered as a 1-Hour Infusion in Ewing Sarcoma Patients in Combination with Low Dose Irinotecan and 3'Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging
No longer recruiting/follow-up only
6-125 Years
NCI
18
21-C-0019
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients with Relapsed/Refractory Hairy Cell Leukemia and Variant
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0017
Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0015
Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0014
Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
Participants currently recruited/enrolled
18-120 Years
NCI
18
21-C-0013
A Phase I/II Study of Adjuvant PRGN-2012 in Adult Patients with Recurrent Respiratory Papillomatosis
No longer recruiting/follow-up only
18-120 Years
NCI
18
21-C-0012
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis from Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0007
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Participants currently recruited/enrolled
18-120 Years
NCI
18
21-C-0006
Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
21-C-0001
A Phase I/II Study of M9241 with Docetaxel and Abiraterone in Adults with Metastatic Castration Sensitive and M9241 with Docetaxel in Castration Resistant Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-NR-0003
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
Participants currently recruited/enrolled
18-70 Years
NINR
18
20-N-0105
Layer-specific Contribution to Consolidation of Skill Learning in the Primary Motor Cortex
Participants currently recruited/enrolled
18-50 Years
NINDS
18
20-N-0060
Mechanisms Underlying the Beneficial Effects of Naps on Motor Learning
Participants currently recruited/enrolled
18-80 Years
NINDS
18
20-N-0048
Corticotrophin-Releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing's Disease
Recruitment has not started
8-125 Years
NINDS
18
20-N-0019
The Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing's Disease
Participants currently recruited/enrolled
18-125 Years
NINDS
18
20-M-0159
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Participants currently recruited/enrolled
14-25 Years
NIMH
18
20-M-0157
PET Imaging of Cyclooxygenase in Participants with Major Depressive Disorder (MDD)
Participants currently recruited/enrolled
18-70 Years
NIMH
18
20-M-0082
Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Participants currently recruited/enrolled
18-99 Years
NIMH
18
20-I-0160
Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
Participants currently recruited/enrolled
18-50 Years
NIAID
18
20-I-0132
A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES)
Participants currently recruited/enrolled
12-130 Years
NIAID
18
20-I-0123
A Longitudinal Study of COVID-19 Sequelae and Immunity
Participants currently recruited/enrolled
18-125 Years
NIAID
18
20-I-0111
COVID-19-associated Lymphopenia Pathogenesis Study in Blood
Participants currently recruited/enrolled
18-125 Years
NIAID
18
20-HG-0156
A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Assess The Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-Onset GM2 Gangliosidosis (Tay-Sachs Disease And Sandhoff Disease)
No longer recruiting/follow-up only
2-125 Years
NHGRI
18
20-HG-0025
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy
Participants currently recruited/enrolled
18-125 Years
NHGRI
18
20-H-0068
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
No longer recruiting/follow-up only
18-80 Years
NHLBI
18
20-H-0044
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Completed Study; data analyses ongoing
18-80 Years
NHLBI
18
20-H-0029
An Intravenous, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
20-H-0021
Treatment of Refractory Diamond-Blackfan Anemia with Eltrombopag
Completed Study; data analyses ongoing
2-99 Years
NHLBI
18
20-E-0143
Serological Surveillance for COVID-19 in Central North Carolina
Completed Study; data analyses ongoing
18-100 Years
NIEHS
18
20-DA-N014
Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD: A Dose-Finding Pilot and Within-Subject Randomized Inpatient Trial
Participants currently recruited/enrolled
18-75 Years
NIDA
18
20-D-0131
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome; a Phase Ib-IIa Placebo-controlled Clinical Trial and Associated Mechanistic Studies
Participants currently recruited/enrolled
18-75 Years
NIDCR
18
20-D-0094
Transmissibility and Viral Load of SARS-CoV-2 Through Oral Secretions
Completed Study; data analyses ongoing
18-125 Years
NIDCR
18
20-CC-0113
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons (COVID ARC 19)
Completed Study; data analyses ongoing
18-80 Years
CC
18
20-CC-0039
A Feasibility Study to Evaluate the Combination of Electromagnetic Tracking and Optical Imaging with Indocyanine Green (ICG) for Hepatic Biopsies
Enrolling by Invitation
18-100 Years
CC
18
20-CC-0036
Exploring a Dietary Behavior Intervention in African-Americans at Risk for Cardiovascular Disease: A Community Acceptability and Feasibility Study
Participants currently recruited/enrolled
18-99 Years
CC
18
20-CC-0031
A single cohort study collecting interval timed incisional epidermal and dermal tissue samples during surgical procedures to profile temporal response of tissue after noxious stimuli.
Completed Study; data analyses ongoing
18-125 Years
CC
18
20-C-0167
Close Assessment and Testing for Chronic Graft-vs-Host Disease (CATCH Study)
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0164
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0162
A Phase 1 Study of Venetoclax with Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0155
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination with BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) with CV301 TRICOM in Advanced Solid Tumors (STAT)
Completed Study; data analyses ongoing
18-120 Years
NCI
18
20-C-0154
Pilot Study of DS-8201a Pharmacodynamics in Patients with HER2-expressing Advanced Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
20-C-0150
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0149
Phase II Trial of Olaparib (LYNPARZA) plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas that Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0142
A Phase II Study of Bintrafusp alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects with Urothelial Carcinoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
20-C-0138
Phase II Trial of Combination Immunotherapy in Subjects with Advanced Small Bowel and Colorectal Cancers
No longer recruiting/follow-up only
18-120 Years
NCI
18
20-C-0127
A Phase 1 Study of Romidepsin, CC-486 (5-azacitidine), dexamethasone, and lenalidomide (RAdR) for relapsed/refractory T-cell malignancies
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0121
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Participants currently recruited/enrolled
18-120 Years
NCI
18
20-C-0104
Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination with Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects with HPV Positive Cancers
No longer recruiting/follow-up only
18-120 Years
NCI
18
20-C-0103
Investigation of the B- and T-cell Repertoire and Immune Response in Patients with Acute and Resolved COVID-19 Infection
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0097
A Phase II, Open-Label Trial of Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0076
Phase 2 Trial of Encorafenib plus Binimetinib for Patients with BRAF V600 Mutated Relapsed/Refractory HCL
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0075
Phase 2 Trial for Binimetinib for Patients with Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0070
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients with Inborn Errors of Immunity
Participants currently recruited/enrolled
4-69 Years
NCI
18
20-C-0069
A First-In-Human Phase I Single-Agent Dose-Escalation and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0065
A Phase II Feasibility Trial Using Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0062
A phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0061
Phase I/II study of NHS-IL12 Monotherapy and in Combination with M7824 in Advanced Kaposi Sarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0058
A Study of Front Line Ibrutinib without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0051
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
Enrolling by Invitation
18-120 Years
NCI
18
20-C-0045
Phase I/II Trial of Combination Immunotherapy in Subjects with Advanced HPV Associated Malignancies
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0028
Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults with Relapsed/Refractory Acute Myeloid Leukemia
Participants currently recruited/enrolled
3-35 Years
NCI
18
20-C-0027
A Phase I Clinical Trial of Selinexor (KPT-330) in Combination with Temozolomide and Radiation Therapy in Patients with Newly Diagnosed Glioblastoma
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0024
A Sequential Window of Opportunity Trial of Anti-PD-L1/TGF-beta trap (M7824 ) Alone and in Combination with TriAd Vaccine, and N-803 for Resectable Head and Neck Squamous Cell Carcinoma not Associated with Human Papillomavirus Infection.
Completed Study; data analyses ongoing
18-120 Years
NCI
18
20-C-0023
First-in-Human Phase I Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Metarrestin (ML-246) in Subjects with Metastatic Solid Tumors
Participants currently recruited/enrolled
12-120 Years
NCI
18
20-C-0022
Phase II trial of VB-111 in Combination with Nivolumab in Patients with Metastatic Colorectal Cancer (mCRC)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
20-C-0020
Ex-Vivo Trial of En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0013
Phase I/II Trial of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0012
A Phase I Study of Bintrafusp alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination with Stereotactic Body Radiation Therapy (SBRT) in Adults with Metastatic Non-Prostate Genitourinary Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0011
Phase 1 Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Completed Study; data analyses ongoing
18-125 Years
NCI
18
20-C-0010
Phase II Trial of Radium-223 in Biochemically Recurrent Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-C-0009
Randomized Phase II Trial of Topotecan Plus M6620 (VX-970) vs. Topotecan Alone in Patients with Relapsed Small-Cell Lung Cancer
No longer recruiting/follow-up only
18-125 Years
NCI
18
20-C-0006
A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC)
Participants currently recruited/enrolled
18-125 Years
NCI
18
20-AR-0032
Genomic Effects of Glucocorticoids in Patients with Systemic Lupus Erythematosus
Completed Study; data analyses ongoing
18-80 Years
NIAMS
18
19-NR-0098
Patient-Centered Assessment of Symptoms and Outcomes
Participants currently recruited/enrolled
18-125 Years
NINR
18
19-N-0124
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Completed Study; data analyses ongoing
18-120 Years
NINDS
18
19-N-0081
A Traveling Subject Study of Replicability in Conventional and Advanced MRI MS Biomarkers
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
19-N-0036
Exploring the Relationship Between Brain Asymmetry and Attention
Completed Study; data analyses ongoing
18-35 Years
NINDS
18
19-M-0107
The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients with Treatment-Resistant Major Depression
Participants currently recruited/enrolled
18-70 Years
NIMH
18
19-M-0079
Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
Participants currently recruited/enrolled
18-99 Years
NIMH
18
19-I-0140
A Phase 1 Evaluation of the Safety of Belimumab in People with Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Participants currently recruited/enrolled
18-70 Years
NIAID
18
19-I-0133
Paradoxical Tuberculosis Reactions in Patients without HIV Infection
Participants currently recruited/enrolled
18-125 Years
NIAID
18
19-I-0126
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
Completed Study; data analyses ongoing
18-125 Years
NIAID
18
19-I-0093
Collection of Human Biospecimens for Basic and Clinical Research into Globin Variants
Participants currently recruited/enrolled
18-70 Years
NIAID
18
19-I-0084
Skin Immunity Sample Collection Involving Blisters and Biopsies
Enrolling by Invitation
7-65 Years
NIAID
18
19-I-0069
Phase I Open-Label Study of Safety and Immunogenicity of AD4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Participants currently recruited/enrolled
18-65 Years
NIAID
18
19-I-0058
Mucosal Correlates of Protection After Influenza Viral Challenge of Vaccinated and Unvaccinated Healthy Volunteers
Completed Study; data analyses ongoing
18-55 Years
NIAID
18
19-I-0027
A Phase 2 Randomized Double-Blinded Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in Subjects with Indolent Systemic Mastocytosis
Completed Study; data analyses ongoing
18-75 Years
NIAID
18
19-HG-0092
New Approaches for Empowering Studies of Asthma in Populations of African Descent
Completed Study; data analyses ongoing
18-125 Years
NHGRI
18
19-H-0139
Investigation of the Natural Progression of Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance.
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
19-H-0111
Early Clonal Dynamics During Venetoclax Treatment for Chronic Lymphocytic Leukemia (CLL)
Participants currently recruited/enrolled
18-125 Years
NHLBI
18
19-H-0100
Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy
Completed Study; data analyses ongoing
18-125 Years
NHLBI
18
19-H-0097
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Multiple Oral Doses of AG-348 in Subjects with Stable Sickle Cell Disease
Completed Study; data analyses ongoing
18-70 Years
NHLBI
18
19-H-0057
Multiple Patient Program for Lamprene (clofazimine) for the treatment of Non-Tuberculous Mycobacterial (NTM) Infections- CLAM320B2002M
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
19-H-0001
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Na(SqrRoot) ve or Receiving Bruton s-tyrosine Kinase Inhibitor (BTK-I) Therapy
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
19-EI-0056
A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures.
Completed Study; data analyses ongoing
12-100 Years
NEI
18
19-E-0110
Reproductive Axis Maturation in the Early Post-Menarchal Years: A Pilot Study
Participants currently recruited/enrolled
8-34 Years
NIEHS
18
19-DK-0072
Non-Alcoholic Fatty Liver Disease, the Hepatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Participants currently recruited/enrolled
18-125 Years
NIDDK
18
19-DK-0067
Effect of Low Fat versus Low Carbohydrate Diets on Energy Metabolism
Completed Study; data analyses ongoing
18-50 Years
NIDDK
18
19-DK-0066
The Evaluation and Management of Endocrine-Related Conditions and Physiology
Participants currently recruited/enrolled
18-90 Years
NIDDK
18
19-DA-N075
Manipulating Ghrelin Signaling via GOAT Inhibition in Alcohol Use Disorder
Completed Study; data analyses ongoing
18-70 Years
NIDA
18
19-CC-0063
Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
18
19-CC-0005
Short or Long Infusion Duration for Platelets: The SOLID Platelet Study
Participants currently recruited/enrolled
18-100 Years
CC
18
19-C-0138
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0137
A Phase II Study of Ipilimumab, Cabozantinib, and NIvolumab in Rare Genitourinary Cancers (ICONIC)
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0132
Incidental Detection of Maternal Neoplasia Through Non-invasive Cell-Free DNA Analysis (IDENTIFY), a Natural History Study
Participants currently recruited/enrolled
18-100 Years
NHGRI
18
19-C-0129
A Phase II Study of Intraperitoneal and Intravenous Paclitaxel Chemotherapy with Oral Capecitabine for Gastric Adenocarcinoma with Peritoneal Carcinomatosis
No longer recruiting/follow-up only
18-125 Years
NCI
18
19-C-0128
A Phase I Study of Mesothelin-Targeted Immunotoxin LMB-100 in Combination with Tofacitinib in Persons with Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and other Mesothelin Expressing Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
19-C-0123
DURVA PLUS: Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination with Chemotherapy in Patients with Advanced Solid Tumors
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0117
A Phase 1 / 2 Single Arm Open-label Clinical Trial of Gavocabtagene Autoleucel (gavo-cel) in Patients with Advanced Mesothelin Expressing Cancer
No longer recruiting/follow-up only
18-120 Years
NCI
18
19-C-0116
A Phase 2 Study of Acalabrutinib with DA-EPOCH-R or R-CHOP for Patients with Untreated Diffuse Large B-cell Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0104
A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0103
A Study of Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas with Secondary Involvement of the Central Nervous System (CNS)
No longer recruiting/follow-up only
18-125 Years
NCI
18
19-C-0102
A Phase I Clinical Trial of T-cells Expressing an anti-SLAMF7 CAR for Treating Multiple Myeloma
Completed Study; data analyses ongoing
18-73 Years
NCI
18
19-C-0096
Studying the Biology of IDH-mutant Gliomas via Longitudinal Observation of 2-Hydroxyglutarate (2-HG) Using MR Spectroscopy
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0094
A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinoma (BTC)
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0085
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T cell Lymphoma
Participants currently recruited/enrolled
12-120 Years
NCI
18
19-C-0062
A Phase II Study of Neoadjuvant Androgen Deprivation Therapy Combined with Enzalutamide and Abiraterone Using Multiparametric MRI and 18F-DCFPyL-PET/CT in Newly Diagnosed Prostate Cancer
No longer recruiting/follow-up only
18-125 Years
NCI
18
19-C-0046
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells.
No longer recruiting/follow-up only
18-125 Years
NCI
18
19-C-0042
A Phase I Study of Moxetumomab Pasudotox-tdfk (Lumoxiti (TM)) and either Rituximab (Rituxan (R)) or Ruxience for Relapsed Hairy Cell Leukemia
No longer recruiting/follow-up only
18-125 Years
NCI
18
19-C-0041
Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
19-C-0039
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Completed Study; data analyses ongoing
18-125 Years
NCI
18
19-C-0033
Phase II Study of Nivolumab (anti-PD1), Tadalafil and Oral Vancomycin in Patients with Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer from Colorectal or Pancreatic Cancers
Completed Study; data analyses ongoing
18-125 Years
NCI
18
19-C-0025
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Enrolling by Invitation
18-125 Years
NCI
18
19-C-0023
A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma and other genitourinary tumors with DNA-Repair Defects
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-C-0017
A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced with a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Participants currently recruited/enrolled
18-72 Years
NCI
18
19-C-0016
Natural History and Biospecimen Acquisition Study for Children and Adults with Rare Solid Tumors
Participants currently recruited/enrolled
0-125 Years
NCI
18
19-C-0010
A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients with Advanced Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
19-C-0006
Phase II Trial Evaluating Nivolumab In Patients With IDH-Mutant Gliomas With And Without Hypermutator Phenotype
Participants currently recruited/enrolled
18-125 Years
NCI
18
19-AT-0089
Sensory Afferents for Deep Pressure Sensation
Completed Study; data analyses ongoing
18-50 Years
NCCIH
18
18-N-0140
Clinical Laboratory Evaluation of Chronic Autonomic Failure
No longer recruiting/follow-up only
18-120 Years
NINDS
18
18-N-0133
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
Participants currently recruited/enrolled
18-85 Years
NINDS
18
18-N-0083
ASPIRO: A Phase 1/2/3, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients
No longer recruiting/follow-up only
3-5 Years
NINDS
18
18-N-0077
Cytokine Microdialysis For Real Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
18-N-0066
Investigating Epilepsy: Screening and Evaluation
Participants currently recruited/enrolled
8-125 Years
NINDS
18
18-N-0020
The Natural History of Blood-Brain Barrier Disruption in Stroke Patients with White Matter Hyperintensities (A Cohort Study)
Completed Study; data analyses ongoing
18-99 Years
NINDS
18
18-M-0144
The Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-withdrawal-induced Mood Symptoms in Women with Past Perimenopausal Depression
Participants currently recruited/enrolled
45-65 Years
NIMH
18
18-M-0037
Characterization and Treatment of Adolescent Depression
Participants currently recruited/enrolled
11-25 Years
NIMH
18
18-M-0015
Development of Non-Invasive Brain Stimulation Techniques
Participants currently recruited/enrolled
18-65 Years
NIMH
18
18-I-0139
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
Completed Study; data analyses ongoing
18-64 Years
NIAID
18
18-I-0128
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
Participants currently recruited/enrolled
0-99 Years
NIAID
18
18-I-0101
Sample Collection From Healthy Volunteers for Assay Optimization
Participants currently recruited/enrolled
18-125 Years
NIAID
18
18-I-0092
A Phase 2, Open-Label Study to Assess the Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in Patients with Idiopathic CD4 T cell Lymphocytopenia
Participants currently recruited/enrolled
18-70 Years
NIAID
18
18-I-0041
Investigating the Mechanistic Biology of Primary Immunodeficiency Disorders
Participants currently recruited/enrolled
0-75 Years
NIAID
18
18-I-0039
Challenge Infection of Healthy Adult Volunteers with RSV A2
Completed Study; data analyses ongoing
18-50 Years
NIAID
18
18-I-0030
VRC 603: A Phase 1 Dose-Escalation Study of the Safety of AAV8-VRC07 (VRC-HIVAAV070-00-GT) Recombinant AAV Vector Expressing VRC07 HIV-1 Neutralizing Antibody in Antiretroviral-Treated, HIV-1 Infected Adults with Controlled Viremia
No longer recruiting/follow-up only
18-65 Years
NIAID
18
18-I-0022
Use of Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients with Leukocyte Adhesion Deficiency Type 1 (LAD1) who have Inflammatory Pathology
Participants currently recruited/enrolled
12-65 Years
NIAID
18
18-HG-0129
Reverse Phenotyping Core (RPC)
Enrolling by Invitation
4-120 Years
NHGRI
18
18-HG-0064
A Natural History Study of Patients with Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
Completed Study; data analyses ongoing
1-110 Years
NHGRI
18
18-H-0146
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
Participants currently recruited/enrolled
18-80 Years
NHLBI
18
18-H-0118
Technical and Translational Development of Cardiovascular MRI (CMR)
Participants currently recruited/enrolled
7-100 Years
NHLBI
18
18-H-0108
Vascular Disease Discovery Protocol
Participants currently recruited/enrolled
2-100 Years
NHLBI
18
18-H-0090
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH using Peripheral Blood Stem Cells and post-transplant Cyclophosphamide for GVHD Prophylaxis
Participants currently recruited/enrolled
4-75 Years
NHLBI
18
18-H-0019
Effect of Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
18-H-0012
A Phase I Study of HERV-E TCR Transduced Autologous T Cells in Patients with Metastatic Clear Cell Renal Cell Carcinoma
No longer recruiting/follow-up only
18-75 Years
NHLBI
18
18-H-0011
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
18-H-0004
Low Dose Danazol for the Treatment of Telomere Related Diseases
Participants currently recruited/enrolled
3-99 Years
NHLBI
18
18-H-0003
Discovery of Sirolimus Sensitive Biomarkers in Blood
Participants currently recruited/enrolled
18-90 Years
NHLBI
18
18-EI-0068
An Investigation of Vitamin A Palmitate Supplementation in Patients with Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation
Completed Study; data analyses ongoing
50-120 Years
NEI
18
18-EI-0067
An Investigation of Vitamin A Palmitate Supplementation in Patients with Age-Related Macular Degeneration (and without reticular pseudodrusen) and Delayed Dark Adaptation
Completed Study; data analyses ongoing
50-120 Years
NEI
18
18-EI-0046
Perception, Sensation, Cognition and Action in Humans
Participants currently recruited/enrolled
18-65 Years
NEI
18
18-DK-N071
Early Tracking of Childhood Health Determinants Study
Participants currently recruited/enrolled
0-99 Years
NIDDK
18
18-DK-0132
Brain Dopamine Function in Human Obesity
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
18-DK-0123
Treatment of Chronic Delta Hepatitis with Lonafarnib, Ritonavir and Lambda Interferon
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
18-DK-0091
Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
No longer recruiting/follow-up only
18-120 Years
NIDDK
18
18-DK-0044
Effect of Ultra Processed versus Unprocessed Diets on Energy Intake
Completed Study; data analyses ongoing
18-50 Years
NIDDK
18
18-DC-0051
Biospecimen Procurement for the Study of Head and Neck Disorders
Participants currently recruited/enrolled
3-120 Years
NCI
18
18-DA-N095
Just-In-Time Adaptive Interventions for Addictive Behaviors
Participants currently recruited/enrolled
18-75 Years
NIDA
18
18-DA-N042
Understanding the Acute Modulation of Brain Activity by Transcranial Magnetic Stimulation
Participants currently recruited/enrolled
18-60 Years
NIDA
18
18-D-0121
Natural History of Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
Participants currently recruited/enrolled
18-100 Years
NIDCR
18
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
Completed Study; data analyses ongoing
18-125 Years
NIDCR
18
18-CH-0120
A Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and the Genotype-Phenotype Correlation
Completed Study; data analyses ongoing
0-120 Years
NICHD
18
18-CH-0031
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Clinical hold/Recruitment or enrollment suspended
7-70 Years
NIDDK
18
18-CH-0002
Investigations of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
Participants currently recruited/enrolled
0-100 Years
NICHD
18
18-CH-0001
Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
Clinical hold/Recruitment or enrollment suspended
0-65 Years
NICHD
18
18-CC-0117
PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects
Completed Study; data analyses ongoing
18-70 Years
CC
18
18-CC-0087
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
18
18-CC-0079
Pilot RCT of Web-based Behavioral Sleep Intervention for Individuals with Alcohol Use Disorder
Completed Study; data analyses ongoing
18-65 Years
CC
18
18-CC-0052
Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers with or at high-risk for Cerebral Palsy and Autism Spectrum Disorder Compared to Infants and Toddlers with Typical Development
Participants currently recruited/enrolled
0-5 Years
CC
18
18-CC-0013
A Randomized, Double-Blind, Placebo-Controlled Study of a Single Dose of Pembrolizumab in HIV-Infected Patients
Participants currently recruited/enrolled
18-99 Years
CC
18
18-C-0147
Phase 1 with Expansion Cohorts in a Study of NEO-201 In Adults with Chemo-Resistant Solid Tumors
Participants currently recruited/enrolled
18-125 Years
NCI
18
18-C-0143
A Phase 1 Study of Intraperitoneal MCY-M11 Therapy for Women with Platinum Resistant High Grade Serous Adenocarcinoma of the Ovary, Primary Peritoneum, or Fallopian Tube, or Subjects with Peritoneal Mesothelioma with Recurrence after Prior Chemotherapy
Completed Study; data analyses ongoing
18-125 Years
NCI
18
18-C-0138
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma.
No longer recruiting/follow-up only
18-125 Years
NCI
18
18-C-0135
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Participants currently recruited/enrolled
4-125 Years
NCI
18
18-C-0125
A Phase I Clinical Trial of T cells Expressing a Novel Fully-human Anti-BCMA CAR for Treating Multiple Myeloma
No longer recruiting/follow-up only
18-73 Years
NCI
18
18-C-0122
Phase 1B Study of Copanlisib in Combination with Nivolumab or with Nivolumab and Ipilimumab
Completed Study; data analyses ongoing
18-125 Years
NCI
18
18-C-0110
Safety Run-In and Phase II Trial of M7824 and Topotecan or Temozolomide in Relapsed Small Cell Cancers
Participants currently recruited/enrolled
18-99 Years
NCI
18
18-C-0102
Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults with Neurofibromatosis Type 1 (NF1) and Cutaneous Neurofibromas (cNF)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
18-C-0093
Pilot Study of Medication Adherence in Children, Adolescents, and Adults with Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials
Completed Study; data analyses ongoing
3-59 Years
NCI
18
18-C-0080
Feasibility and Preliminary Efficacy of an Enhanced Mindfulness Intervention for Children and Young Adults with High Grade or High-Risk Cancer and Their Caregivers: A Pilot Randomized Controlled Trial
Completed Study; data analyses ongoing
5-125 Years
NCI
18
18-C-0078
A Phase I/II Study of Immunotherapy Combination BN-Brachyury vaccine, M7824, N-803 and Epacadostat (QuEST1)
No longer recruiting/follow-up only
18-120 Years
NCI
18
18-C-0062
Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Completed Study; data analyses ongoing
2-30 Years
NCI
18
18-C-0059
Phase 1 Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults with Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Participants currently recruited/enrolled
3-39 Years
NCI
18
18-C-0058
A Pilot Study to Evaluate the Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Completed Study; data analyses ongoing
18-125 Years
NCI
18
18-C-0056
Phase II Trial of M7824 in Subjects with HPV Associated Malignancies
Completed Study; data analyses ongoing
18-120 Years
NCI
18
18-C-0049
A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in Patients with Metastatic Cancer
Participants currently recruited/enrolled
18-72 Years
NCI
18
18-C-0033
Phase I Study of Recombinant Interleukin 15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in Subjects with Refractory Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
18-C-0028
A Phase I Trial of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
No longer recruiting/follow-up only
18-125 Years
NCI
18
18-C-0024
A Single-Arm Phase II Study of Hepatic Artery Infusion Pump Chemotherapy with Floxuridine and Dexamethasone in Combination with Systemic Chemotherapy for Patients with Colorectal Cancer Metastatic to the Liver
Participants currently recruited/enrolled
18-125 Years
NCI
18
18-C-0017
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
18-C-0014
Phase I Trial of 5-aza-4'-thio-2'-Deoxycytidine (Aza-TdC) in Patients with Advanced Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
18
18-C-0008
Phase III Randomized Adjuvant study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) versus Observation
No longer recruiting/follow-up only
18-125 Years
NCI
18
18-C-0005
Phase II Trial of Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
No longer recruiting/follow-up only
18-125 Years
NCI
18
18-AR-0081
Investigation of the Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease and Related Inflammatory Conditions
Participants currently recruited/enrolled
0-125 Years
NIAMS
18
18-AA-0098
Investigating a Response Modulation Hypothesis of Socioemotional Processing associated with Alcohol Use Disorder
Participants currently recruited/enrolled
21-65 Years
NIAAA
18
18-AA-0047
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Participants currently recruited/enrolled
18-60 Years
NIAAA
18
17-N-0168
Influence of Brain Oscillation-Dependent TMS on Motor Function
Participants currently recruited/enrolled
18-125 Years
NINDS
18
17-N-0145
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
Completed Study; data analyses ongoing
18-120 Years
NINDS
18
17-N-0131
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Participants currently recruited/enrolled
18-125 Years
NINDS
18
17-N-0035
Clinical and Physiological Studies of Tremor Syndromes
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
17-MD-0015
Understanding how cigarette direct mail marketing influence smoking behaviors among high and low socioeconomic status young adult smokers
Participants currently recruited/enrolled
18-29 Years
NIMHD
18
17-M-0181
Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies
No longer recruiting/follow-up only
18-125 Years
NIMH
18
17-M-0179
Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)
Completed Study; data analyses ongoing
18-99 Years
NIMH
18
17-M-0147
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes
Participants currently recruited/enrolled
18-75 Years
NIMH
18
17-M-0060
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Participants currently recruited/enrolled
18-65 Years
NIMH
18
17-I-0101
An Open-Label, Proof of Concept Study of Vorinostat for the Treatment of Moderate-to-Severe Crohn's Disease and Maintenance Therapy with Ustekinumab
Participants currently recruited/enrolled
18-65 Years
NIAID
18
17-I-0083
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Participants currently recruited/enrolled
18-125 Years
NIAID
18
17-I-0072
Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)
Completed Study; data analyses ongoing
18-99 Years
NIAID
18
17-I-0067
Sanaria PfSPZ Challenge with Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Dose Escalation Trial to Determine Safety and Development of Protective Efficacy after Exposure to Only Pre-erythrocytic Stages of Plasmodium falciparum
Completed Study; data analyses ongoing
18-50 Years
NIAID
18
17-I-0016
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
Participants currently recruited/enrolled
0-99 Years
NIAID
18
17-H-0146
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
17-H-0095
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires
Participants currently recruited/enrolled
18-125 Years
NHLBI
18
17-H-0069
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
No longer recruiting/follow-up only
2-100 Years
NHLBI
18
17-H-0056
Pathophysiology of Acute Pain in Patients with Sickle Cell Disease
Completed Study; data analyses ongoing
18-80 Years
NHLBI
18
17-DK-N004
Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans
Completed Study; data analyses ongoing
18-55 Years
NIDDK
18
17-DK-0054
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment with Beta3-Adrenergic Receptor Agonists
Participants currently recruited/enrolled
18-40 Years
NIDDK
18
17-DA-N002
Neuroplasticity Following Theta-Burst Stimulation in Cocaine Use Disorder
Participants currently recruited/enrolled
22-60 Years
NIDA
18
17-CC-0148
Obtaining Samples from Human Subjects to Facilitate Basic, Translational and Clinical Research
Participants currently recruited/enrolled
18-100 Years
CC
18
17-C-0174
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Participants currently recruited/enrolled
18-125 Years
NCI
18
17-C-0158
A Feasibility Study of Mobile Sensor Technologies to Assess General Symptomology of Cancer Patients
Enrolling by Invitation
18-120 Years
NCI
18
17-C-0157
A Phase I Single-Arm Study of the Combination of Durvalumab (MEDI4736) and Vicineum (oportuzumab monatox, VB4-845) in Subjects with High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated with Bacillus Calmette-Gu(SqrRoot)(Copyright)rin (BCG)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0156
Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic, National Cancer Institute
Participants currently recruited/enrolled
18-125 Years
NCI
18
17-C-0153
Phase I Trial of Image Guided Focally Dose Escalated Prostate SBRT for Locally Recurrent Prostate Cancer after Prior Radiotherapy
No longer recruiting/follow-up only
18-125 Years
NCI
18
17-C-0140
Phase I/II Evaluation of Oral Decitabine/Tetrahydrouridine as Epigenetic Priming for Pembrolizumab Immune Checkpoint Blockade in Inoperable Locally Advanced or Metastatic Non-Small Cell Lung Cancers, Esophageal Carcinomas, or Pleural Mesotheliomas
Completed Study; data analyses ongoing
18-99 Years
NCI
18
17-C-0127
Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
17-C-0115
Phase I/II Study of T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0113
A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced with a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Participants currently recruited/enrolled
18-72 Years
NCI
18
17-C-0109
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Enrolling by Invitation
18-125 Years
NCI
18
17-C-0105
Prospective Study of Clonal Evolution in Follicular Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
17-C-0100
Collection of Malignant Ascites, Pleural Fluid and Blood from Patients with Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0089
Evaluation of 18F-DCFPyL PSMA- versus 18F-NaF-PET imaging for Detection of Metastatic Prostate Cancer
Enrolling by Invitation
18-125 Years
NCI
18
17-C-0086
An Open-label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma
No longer recruiting/follow-up only
18-125 Years
NCI
18
17-C-0070
Phase II Trial of Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer with Positive Peritoneal Cytology
No longer recruiting/follow-up only
18-125 Years
NCI
18
17-C-0066
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma after Progression on Platinum-Based Chemotherapy
Participants currently recruited/enrolled
18-125 Years
NCI
18
17-C-0061
Phase II Trial of Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0045
A Phase I Study of Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0037
Phase II Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0034
A Randomized, Double Blind Phase II Trial of Surgery, Radiation Therapy Plus Temozolomide and Pembrolizumab with and without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0027
Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation
Participants currently recruited/enrolled
4-125 Years
NCI
18
17-C-0011
Phase 1 Study of Intraperitoneal Infusion of Autologous Monocytes with Sylatron(R) (Peginterferon alfa-2b) and Actimmune(R) (Interferon gamma-1b) in Women with Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0009
Phase I Trial of Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide (tmz) Followed by Randomized Phase II Trial of Zotiraciclib (TG02) plus Temozolomide versus Temozolomide alone in Adults with Recurrent Anaplastic Astrocytoma and Glioblastom
Completed Study; data analyses ongoing
18-125 Years
NCI
18
17-C-0007
Phase I/II Study of PROSTVAC in Combination with Nivolumab in Men with Prostate Cancer
Completed Study; data analyses ongoing
18-120 Years
NCI
18
17-AT-0155
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
Participants currently recruited/enrolled
18-60 Years
NCCIH
18
17-AA-0178
Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI
Completed Study; data analyses ongoing
18-55 Years
NIAAA
18
17-AA-0152
Ketogenic Diet (KD) in Alcoholism
Completed Study; data analyses ongoing
18-125 Years
NIAAA
18
17-AA-0114
Brain Dopaminergic Signaling in Opioid use Disorders (OUD)
Participants currently recruited/enrolled
18-80 Years
NIAAA
18
16-N-0170
Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation
Completed Study; data analyses ongoing
18-75 Years
NINDS
18
16-N-0166
Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia
No longer recruiting/follow-up only
22-100 Years
NINDS
18
16-N-0072
A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-cells
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
16-N-0064
Cholinergic Receptor Imaging in Dystonia
Completed Study; data analyses ongoing
18-100 Years
NINDS
18
16-N-0058
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Completed Study; data analyses ongoing
18-60 Years
NINDS
18
16-N-0055
The Pathological Basis of MRI Signal Changes in Multiple Sclerosis: A Longitudinal In Vivo-to-Postmortem Study
Participants currently recruited/enrolled
18-120 Years
NINDS
18
16-N-0031
An All-Night Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli
Participants currently recruited/enrolled
18-34 Years
NINDS
18
16-I-0078
Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME study)
Participants currently recruited/enrolled
18-49 Years
NIAID
18
16-I-0065
Screening for Alpha Globin Deletions
No longer recruiting/follow-up only
18-39 Years
NIAID
18
16-I-0053
A Multicenter Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVdeltaG-ZEBOV GP) for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebola Virus Exposure (PREPARE)
No longer recruiting/follow-up only
18-125 Years
NIAID
18
16-I-0039
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
Participants currently recruited/enrolled
18-50 Years
NIAID
18
16-H-0132
CADASIL Disease Discovery
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
16-H-0129
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Completed Study; data analyses ongoing
18-39 Years
NHLBI
18
16-H-0019
High Image Matrix CT Reconstruction
Completed Study; data analyses ongoing
18-99 Years
NHLBI
18
16-EI-0169
A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis
Completed Study; data analyses ongoing
18-125 Years
NEI
18
16-E-0157
CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)
Completed Study; data analyses ongoing
18-28 Years
NIEHS
18
16-E-0096
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Completed Study; data analyses ongoing
18-65 Years
NIEHS
18
16-DK-0143
Idiosyncratic Liver Injury Associated with Drugs (ILIAD): A Retrospective Study
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
16-DK-0125
Evaluation of Adults with Endocrine-Related Conditions
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
16-DK-0068
The Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and its Role in Metabolism
Participants currently recruited/enrolled
18-90 Years
NIDDK
18
16-DA-0080
A Novel Compound for Alcoholism Treatment: a Translational Strategy - Part II
Completed Study; data analyses ongoing
18-70 Years
NIDA
18
16-D-0040
Natural History of Craniofacial Anomalies and Developmental Growth Variants
Participants currently recruited/enrolled
2-100 Years
NIDCR
18
16-CC-0168
Focus Groups to Determine Surrogates' Views Regarding Patient Preference Predictors
Completed Study; data analyses ongoing
18-90 Years
CC
18
16-CC-0162
Longitudinal Changes in the Oral and Gut Microbiome of Individuals with Alcohol Dependence
Completed Study; data analyses ongoing
18-125 Years
CC
18
16-CC-0098
Pilot Study of Ultrasound Guided Focal Thermal Ablation of Prostate Cancer
Clinical hold/Recruitment or enrollment suspended
18-100 Years
CC
18
16-CC-0049
A Phase II Study Using LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment with Transarterial Embolization (TAE) Alone or Combined with Thermal Ablation
Completed Study; data analyses ongoing
18-100 Years
CC
18
16-CC-0001
Evaluation of MiSeq for Microbial Identification in Specimens
No longer recruiting/follow-up only
2-125 Years
CC
18
16-C-0171
Phase I/II Study of Lenalidomide Combined with Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-Associated Large Cell Lymphoma
No longer recruiting/follow-up only
18-125 Years
NCI
18
16-C-0154
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
Participants currently recruited/enrolled
18-120 Years
NCI
18
16-C-0138
Collection of Peripheral Blood Mononuclear Cells (PBMCs) from Healthy Subjects for the Expansion of T Cells for Adoptive Cell Therapy
Participants currently recruited/enrolled
18-120 Years
NCI
18
16-C-0131
A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced with a CD70-Binding Chimeric Antigen Receptor to Patients with CD70-Expressing Cancers
Participants currently recruited/enrolled
18-72 Years
NCI
18
16-C-0128
A Phase I/II Study of Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination with Nab-Paclitaxel in Participants with Previously Treated Metastatic and/ or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0121
A Pilot Clinical Trial of Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0107
A Phase I/II Trial of EP0057, a Nanoparticle Camptothecin with Olaparib in Patients with Relapsed/Refractory Small Cell Lung, Bladder and Prostate Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
16-C-0094
A Phase 1/2 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (SCT)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0092
A Pilot Study of Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-mutated, Non-Small Cell Lung Cancer (NSCLC) After Treatment with Osimertinib (AZD9291, Tagrisso)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0088
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritonea
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0087
Phase I Study of Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor in Combination with Cisplatin in Patients with Refractory Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0081
A Phase I Dose Escalation Trial of Re-Irradiation in Good Prognosis Recurrent Glioblastoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0076
Prospective Screening for Patient Specific Genotypes and Phenotypes that Influence Drug Dosing and Trial Selection in Cancer Patients
Enrolling by Invitation
18-125 Years
NCI
18
16-C-0073
A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0061
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Participants currently recruited/enrolled
18-120 Years
NCI
18
16-C-0060
A Phase 1b/2 Study of alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
Participants currently recruited/enrolled
18-125 Years
NCI
18
16-C-0048
Docetaxel and Prostvac for Metastatic Castration Sensitive Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0047
A Phase 1 Trial of Pomalidomide in Combination with Liposomal Doxorubicin in Patients with Advanced or Refractory Kaposi Sarcoma
No longer recruiting/follow-up only
18-125 Years
NCI
18
16-C-0043
Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
No longer recruiting/follow-up only
18-125 Years
NCI
18
16-C-0035
Prostvac in Patients with Biochemically Recurrent Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0034
A Phase II Trial of Oral Pazopanib plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) without Prior Bevacizumab Exposure and (B) after Failing Prior Bevacizumab
Completed Study; data analyses ongoing
18-125 Years
NCI
18
16-C-0027
A Prospective Randomized and Phase II Trial for Metastatic Melanoma Using Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Clinical hold/Recruitment or enrollment suspended
18-70 Years
NCI
18
16-C-0010
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Participants currently recruited/enrolled
18-125 Years
NCI
18
16-AT-0136
Effects of External Ear Stimulation on Pain Perception and Mood
Participants currently recruited/enrolled
18-50 Years
NCCIH
18
16-AA-0059
Characterization of Brain Amyloid-beta (A-beta) Retention During Wakefulness And Following Emergence From Sleep In Healthy Subjects
Completed Study; data analyses ongoing
18-40 Years
NIAAA
18
15-N-0177
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Participants currently recruited/enrolled
18-60 Years
NINDS
18
15-N-0175
An Open-Label, Phase 1b Safety and Efficacy Trial of Periganglionic Resiniferatoxin for the Treatment of Intractable Pain due to Cancer-induced Bone Pain
Recruitment has not started
18-150 Years
NINDS
18
15-N-0167
Propensity to Develop Plasticity in the Parieto-motor Network in Dystonia from the Perspective of Abnormal High-Order Motor Processing
Completed Study; data analyses ongoing
18-65 Years
NINDS
18
15-N-0156
In Vivo Characterization of Inflammation with Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
Completed Study; data analyses ongoing
18-70 Years
NINDS
18
15-N-0126
HERV-K Suppression using Antiretroviral Therapy in Volunteers with Amyotrophic Lateral Sclerosis (ALS)
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
15-N-0081
A Study of Direct Brain Recording and Stimulation for Memory Enhancement
Enrolling by Invitation
18-65 Years
NINDS
18
15-M-0188
The Neurobiology of Suicide
Participants currently recruited/enrolled
18-70 Years
NIMH
18
15-M-0151
An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV 101 (4-chlorokynurenine) in Major Depressive Disorder
Completed Study; data analyses ongoing
18-65 Years
NIMH
18
15-M-0139
Mapping the Genotype, Phenotype, and Natural History of Phelan McDermid Syndrome
Participants currently recruited/enrolled
1-125 Years
NIMH
18
15-M-0066
Influence on Plasticity of Brain Temperature
Participants currently recruited/enrolled
18-35 Years
NIMH
18
15-I-0148
A Phase I Study of Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers
Completed Study; data analyses ongoing
18-50 Years
NIAID
18
15-I-0131
Xenodiagnosis after Antibiotic Treatment for Lyme Disease - Phase II Study
Completed Study; data analyses ongoing
18-125 Years
NIAID
18
15-I-0056
Collection of Plasma from Subjects that Recovered From or Were Vaccinated To Emerging Infectious Diseases
Enrolling by Invitation
18-70 Years
NIAID
18
15-H-0155
Hereditary Parkinson Disease Natural History Protocol
Completed Study; data analyses ongoing
18-80 Years
NHLBI
18
15-H-0017
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
15-EI-0038
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Completed Study; data analyses ongoing
18-120 Years
NEI
18
15-E-0058
Natural History of Asthma with Longitudinal Environmental Sampling
Participants currently recruited/enrolled
18-60 Years
NIEHS
18
15-DK-0174
Dynamic Post-Prandial Metabolism in Patients with Non-Alcoholic Fatty Liver Disease
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
15-DK-0170
Treatment of Chronic Delta Hepatitis with Lonafarnib and Ritonavir
Completed Study; data analyses ongoing
18-99 Years
NIDDK
18
15-DK-0143
Investigation of Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected with Different Hepatitis C Virus Genotypes During Therapy with Sofosbuvir and GS-5816
Completed Study; data analyses ongoing
18-80 Years
NIDDK
18
15-DK-0100
A Multidisciplinary Approach to Deciphering the Mechanisms Involved In Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
15-DK-0082
Mechanisms Associated with Favorable Response to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
15-DK-0079
Observational Study of Hepatitis B Virus (HBV) in Patients Coinfected with Human Immunodeficiency Virus (HIV)
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
15-D-0129
Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of an Adeno-Associated Virus Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction.
No longer recruiting/follow-up only
18-100 Years
NIDCR
18
15-D-0051
Characterization of Diseases with Salivary Gland Involvement
Participants currently recruited/enrolled
4-100 Years
NIDCR
18
15-CC-0164
Effect of Exercise Training on Physical, Cognitive and Behavioral Function in Patients with Traumatic Brain Injury
Completed Study; data analyses ongoing
18-79 Years
CC
18
15-CC-0091
Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans
Clinical hold/Recruitment or enrollment suspended
18-45 Years
CC
18
15-C-0200
Molecular Analysis for Therapy Choice (MATCH) (EAY131)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
15-C-0160
A Phase I Study of Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination with Ipilimumab (CaboNivoIpi) in Patients with Advanced/Metastatic Urothelial Carcinoma and other Genitourinary Tumors
No longer recruiting/follow-up only
18-125 Years
NCI
18
15-C-0157
Phase I/II Trial of Vandetanib in Combination with Metformin in Subjects with HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
15-C-0150
A Phase I/II Trial of Topotecan with VX-970 (M6620), an ATR Kinase Inhibitor in Small Cell Cancers
No longer recruiting/follow-up only
18-125 Years
NCI
18
15-C-0145
Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody Durvalumab (MEDI4736) in Combination with Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
18
15-C-0141
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in CAR T-Cell Studies
Enrolling by Invitation
18-125 Years
NCI
18
15-C-0116
Phase I Trial of 4'-thio-2'-deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Clinical hold/Recruitment or enrollment suspended
18-120 Years
NCI
18
15-C-0099
A Phase 1, Open-Label, Dose-Escalation Study of SNX-5422 and Everolimus in Subjects with Neuroendocrine Tumors
Completed Study; data analyses ongoing
18-100 Years
NCI
18
15-C-0087
Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients
Participants currently recruited/enrolled
18-125 Years
NCI
18
15-C-0086
Phase I Trial of the Combination of Nilotinib and Paclitaxel in Adults and Pediatric Patients with Refractory Solid Tumors
Participants currently recruited/enrolled
12-120 Years
NCI
18
15-C-0078
Safety and Feasibility of Stem Cell Gene Transfer Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated with a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs
No longer recruiting/follow-up only
18-65 Years
NCI
18
15-C-0067
A Phase I/II Open Label, Dose Escalation Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Participants currently recruited/enrolled
18-125 Years
NCI
18
15-C-0028
Follow-Up Evaluation for Gene-Therapy Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
Enrolling by Invitation
1-99 Years
NCI
18
15-AT-0132
Neural and Psychological Mechanisms of Pain Perception
Participants currently recruited/enrolled
18-50 Years
NCCIH
18
15-AR-0165
Study of the Natural History, Pathogenesis and Outcome of Melorheostosis - a Rare Osteosclerotic Disease
Participants currently recruited/enrolled
18-90 Years
NIAMS
18
15-AR-0060
The Role of PPAR-gamma Agonists in immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Completed Study; data analyses ongoing
18-99 Years
NIAMS
18
15-AA-0186
Development of Neuroimaging Methods to Assess the Neurobiology of Addiction
Participants currently recruited/enrolled
18-125 Years
NIAAA
18
15-AA-0031
Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) during Sleep and Wakefulness
Completed Study; data analyses ongoing
18-60 Years
NIAAA
18
14-N-0086
Deep Brain Stimulation Therapy in Movement Disorders
Participants currently recruited/enrolled
18-125 Years
NINDS
18
14-N-0083
Neural Basis of Decision Making Deficits in Traumatic Brain Injury
Participants currently recruited/enrolled
18-60 Years
NINDS
18
14-I-0194
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Participants currently recruited/enrolled
18-120 Years
NIAID
18
14-I-0124
PET Imaging and Lymph Node Assessment of IRIS in Persons With AIDS
Participants currently recruited/enrolled
18-125 Years
NIAID
18
14-I-0081
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Benralizumab (MEDI-563) in Reducing Eosinophilia in Subjects with Hypereosinophilic Syndrome (HES)
No longer recruiting/follow-up only
18-75 Years
NIAID
18
14-I-0063
An Open-Label, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects with Hypereosinophilic Syndrome
No longer recruiting/follow-up only
18-125 Years
NIAID
18
14-I-0009
Characterization and Management of Patients with HIV-1 Infection Who Experience Virologic Failure Despite Combination Antiretroviral Therapy
Completed Study; data analyses ongoing
18-100 Years
NIAID
18
14-HG-0125
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers
Participants currently recruited/enrolled
18-120 Years
NHGRI
18
14-HG-0048
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)
Completed Study; data analyses ongoing
21-65 Years
NHGRI
18
14-H-0188
Prospective Evaluation of Next Generation CT Reconstruction
Participants currently recruited/enrolled
18-99 Years
NHLBI
18
14-EI-0171
The Focal Electro-Oculogram in Macular Disease
Completed Study; data analyses ongoing
10-100 Years
NEI
18
14-DK-0195
Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
14-CH-0028
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Participants currently recruited/enrolled
18-80 Years
NIDDK
18
14-CC-0201
A Randomized Controlled Trial to Determine the Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Completed Study; data analyses ongoing
18-125 Years
CC
18
14-C-0161
Phase I Trial of the Combination of Bortezomib and Clofarabine in Adults with Refractory Solid Tumors, Lymphomas, or Myelodysplastic Syndromes
Participants currently recruited/enrolled
18-120 Years
NCI
18
14-C-0157
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, Rituximab (TEDDI-R) in Primary CNS Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
18
14-C-0156
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) In BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
14-C-0105
Tissue Procurement and Natural History Study of Patients with Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Participants currently recruited/enrolled
18-125 Years
NCI
18
14-C-0104
A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived from Patients with Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen
Participants currently recruited/enrolled
18-72 Years
NCI
18
14-C-0079
An Exploratory Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults with Cancer and Other Chronic Illnesses
No longer recruiting/follow-up only
18-125 Years
NCI
18
14-C-0036
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus Calmette-Guerin (BCG) Given in Combination with PANVAC[TM] Versus BCG Given Alone in Adults with High Grade Non-Muscle Invasive Bladder Cancer (NMIBC) Who Failed at Least 1 I
Completed Study; data analyses ongoing
18-125 Years
NCI
18
14-C-0004
A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia
No longer recruiting/follow-up only
18-125 Years
NCI
18
14-AA-0181
NIAAA Natural History Protocol
Participants currently recruited/enrolled
18-100 Years
NIAAA
18
14-AA-0144
Reliability Of The Human Brain Connectome
Completed Study; data analyses ongoing
18-125 Years
NIAAA
18
14-AA-0080
Characterization Imaging Instruments for Addiction Neuroimaging Assessments
Participants currently recruited/enrolled
18-125 Years
NIAAA
18
14-AA-0066
Behavioral and Functional Task Development, Implementation, and Testing
Participants currently recruited/enrolled
18-65 Years
NIAAA
18
13-N-0188
Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
13-N-0149
An Evaluation of HIV-associated Neurocognitive Disorders (HAND) in Virologically Controlled Patients
Participants currently recruited/enrolled
18-110 Years
NINDS
18
13-N-0085
Clinical Manifestations and Biorepository for Focal Dystonia
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
13-I-0172
Phase I Study of the Safety of a Replication-Defective Herpes Simplex Virus-2 Vaccine, HSV529, in Adults Aged 18 to 40 Years With or Without HSV Infection
Completed Study; data analyses ongoing
18-40 Years
NIAID
18
13-I-0082
Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated Diseases
Completed Study; data analyses ongoing
18-125 Years
NIAID
18
13-I-0062
A Double Blind Randomized Placebo Controlled Study Examining the Effects of a Non-Absorbable (Rifaximin) Antibiotic on the Chronic Immune Activation Observed In HIV-infected Subjects
Completed Study; data analyses ongoing
18-65 Years
NIAID
18
13-H-0194
Inflammatory Characterization of Known or Possible Cardiovascular Diseases
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
13-H-0065
Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative
Completed Study; data analyses ongoing
18-99 Years
NHLBI
18
13-H-0059
Longitudinal Observational Study of Severe Asthma
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
13-H-0051
Bronchodilator Effects of Nebulized versus Inhaled Albuterol in Subjects with Lymphangioleiomyomatosis
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
13-EI-0072
Microbiome and Ocular Inflammatory Disease
Completed Study; data analyses ongoing
18-125 Years
NEI
18
13-DK-0212
Effect of a Eucaloric Ketogenic Diet on Energy Expenditure: A Pilot Study
Completed Study; data analyses ongoing
18-50 Years
NIDDK
18
13-DK-0200
The Mechanism of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
Completed Study; data analyses ongoing
18-35 Years
NIDDK
18
13-DK-0091
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir DF versus Tenofovir DF Monotherapy in HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
13-DA-N485
Multimodal Neuroimaging Genetic Biomarkers of Nicotine Addiction Severity
Participants currently recruited/enrolled
18-60 Years
NIDA
18
13-D-0014
Bacterial Arrangement in Supragingival Biofilms
Completed Study; data analyses ongoing
18-999 Years
NIDCR
18
13-CH-0112
Pilot Study to Assess Biomarkers of Changes in Barrier Function of Skeletal Muscle in Patients with a Fragile Sarcolemmal Muscular Dystrophy
No longer recruiting/follow-up only
18-125 Years
NICHD
18
13-CC-0099
Vasti Control of Patellofemoral Kinematics in Patients with Chronic Patellofemoral Pain.
Participants currently recruited/enrolled
18-55 Years
CC
18
13-CC-0012
A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension
Participants currently recruited/enrolled
18-100 Years
CC
18
13-C-0202
Tissue Procurement and Natural History Study of Patients with Malignant Mesothelioma and Other Mesothelin Expressing Cancers
Participants currently recruited/enrolled
2-125 Years
NCI
18
13-C-0176
Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid Tumors
Clinical hold/Recruitment or enrollment suspended
2-125 Years
NCI
18
13-C-0153
A Phase II Trial of Enzalutamide in Combination with PSA-TRICOM in Patients with Non-Metastatic Castration Sensitive Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
13-C-0146
A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC /TRICOM and Enzalutamide vs. Enzalutamide Alone in Men with Metastatic Castration Resistant Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
13-C-0119
Evaluation of Local Response of Prostate Cancer to Irradiation Using Multiparametric MRI and MR-Guided Biopsies
Participants currently recruited/enrolled
18-125 Years
NCI
18
13-C-0118
A Phase I/II Trial of TRC102 (methoxyamine HCl) in Combination with Temozolomide in Patients with Relapsed Solid Tumors and Lymphomas
Completed Study; data analyses ongoing
18-120 Years
NCI
18
13-C-0105
Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Completed Study; data analyses ongoing
18-120 Years
NCI
18
13-C-0095
A Phase 2 Study of GI-6207 in Patients with Recurrent Medullary Thyroid Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
13-AR-0056
Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis
Completed Study; data analyses ongoing
18-125 Years
NIAMS
18
12-N-0137
A Phase 1 Open-Label Dose Escalation Safety Study of Convection Enhanced Delivery (CED) of Adeno-Associated Virus Encoding Glial Cell Line-Derived Neurotrophic Factor (AAV2-GDNF) in Subjects with Advanced Parkinson's Disease
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
12-N-0122
Integrating Genetic and Environmental Risk Scores into an Algorithm to Predict Multiple Sclerosis Susceptibility
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
12-N-0083
The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women with Endometriosis
Completed Study; data analyses ongoing
18-50 Years
NINDS
18
12-N-0031
Imaging Biomarkers in Parkinson Disease
Completed Study; data analyses ongoing
18-100 Years
NINDS
18
12-M-0128
TMS Investigations of the Human Visual System
Participants currently recruited/enrolled
18-50 Years
NIMH
18
12-I-0103
Characterization of Innate Immune Responses to AS03 Adjuvanted H5N1 Vaccine Compared to Non-adjuvanted H5N1 Vaccine
Completed Study; data analyses ongoing
21-45 Years
NIAID
18
12-HG-0202
The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder
Completed Study; data analyses ongoing
3-125 Years
NHGRI
18
12-HG-0181
The Clinical Study of Patients with Sex Chromosome Variants
Completed Study; data analyses ongoing
18-125 Years
NHGRI
18
12-HG-0023
The Role of the Family Genetics Health Educator in Influencing Health Promoting Behaviors
Completed Study; data analyses ongoing
18-125 Years
NHGRI
18
12-H-0141
Prospective Evaluation of New Techniques in Radiation Reduction for Cardiovascular Computed Tomographic Angiography
Participants currently recruited/enrolled
18-100 Years
NHLBI
18
12-H-0035
A Phase II study of Ibrutinib for Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Need Therapy and are Older than 65 or have a 17p Deletion
No longer recruiting/follow-up only
18-125 Years
NHLBI
18
12-E-0190
The Role of Functionally Relevant Cyclooxygenase-2 (COX-2) Gene Single Nucleotide Polymorphisms - 765G>C and 8473T>C in Lymphocyte Differentiation
Completed Study; data analyses ongoing
18-150 Years
NIEHS
18
12-E-0061
The Role of the Functionally Relevant Single Nucleotide Polymorphisms CYP2J2 -50G>T (CYP2J2 7) and EPHX2 9846A>G (EPHX2 K55R) in Human Endothelial Function
Completed Study; data analyses ongoing
18-65 Years
NIEHS
18
12-E-0050
The Role of Gonadotropin Pulsations in the Regulation of Puberty and Fertility
Participants currently recruited/enrolled
14-125 Years
NIEHS
18
12-DK-0097
Energy Expenditure Responses to Different Temperatures
Participants currently recruited/enrolled
18-75 Years
NIDDK
18
12-DK-0071
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-40 Years
NIDDK
18
12-DA-N474
Identifying Neurobiological Mechanisms that Underlie Acute Nicotine Withdrawal and Drive Early Relapse in Smokers
Completed Study; data analyses ongoing
18-65 Years
NIDA
18
12-DA-N472
Health Outcomes by Neighborhood - HON Study Baltimore
Completed Study; data analyses ongoing
18-100 Years
NIDA
18
12-CC-0211
A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension
Participants currently recruited/enrolled
18-100 Years
CC
18
12-CC-0139
Estimation of Brain Biomechanics using MRI
Participants currently recruited/enrolled
18-65 Years
CC
18
12-CC-0096
Collection of Granulocytes by Apheresis of Healthy Donors Stimulated with Filgrastim (G-CSF) and Dexamethasone
Participants currently recruited/enrolled
18-75 Years
CC
18
12-C-0205
A Phase II Study of Cabozantinib (XL184) in Patients With Advanced/Metastatic Urothelial Carcinoma
Completed Study; data analyses ongoing
18-125 Years
NCI
18
12-C-0197
A Randomized Phase 2 Single-Center Study of Pomalidomide for Chronic GvHD
Completed Study; data analyses ongoing
18-75 Years
NCI
18
12-C-0193
Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol
Participants currently recruited/enrolled
18-125 Years
NCI
18
12-C-0118
A Phase II Study of Sunitinib in Patients with Advanced Relapsed or Refractory Thymoma or Thymic Carcinoma with at Least One Prior Line of Platinum-Based Systemic Chemotherapy
No longer recruiting/follow-up only
18-100 Years
NCI
18
12-C-0107
Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: a Clinical and Correlative Pilot Study
No longer recruiting/follow-up only
18-125 Years
NCI
18
12-C-0081
Phase I/II Study of Cediranib and Olaparib in Combination for Treatment of Recurrent Papillary-Serous Ovarian, Fallopian Tube, or Peritoneal Cancer or for Treatment of Recurrent Triple-Negative Breast Cancer
No longer recruiting/follow-up only
18-125 Years
NCI
18
12-C-0079
A Phase II Multicenter Study of AMG 386 and Abiraterone in Metastatic Castration Resistant Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
12-C-0066
Phase I Trial of Oral 5-Fluoro-2'-Deoxycytidine with Oral Tetrahydrouridine in Patients with Advanced Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
12-AR-0159
Effects of Treatments on the Microbiome in Healthy Volunteers and Patients with Atopic Dermatitis
Participants currently recruited/enrolled
2-50 Years
NIAMS
18
11-NR-0014
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
Participants currently recruited/enrolled
18-120 Years
NINR
18
11-N-0211
Deep Brain Stimulation Surgery for Movement Disorders
Participants currently recruited/enrolled
18-99 Years
NINDS
18
11-N-0084
Evaluation and Diagnosis of Potential Research Subjects with Traumatic Brain Injury (TBI)
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
11-M-0045
Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
Participants currently recruited/enrolled
18-65 Years
NIMH
18
11-I-0183
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Participants currently recruited/enrolled
18-65 Years
NIAID
18
11-I-0164
VRC 500: Screening Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes
Participants currently recruited/enrolled
18-60 Years
NIAID
18
11-I-0057
Effect of Interferon Alpha 2b Intensification on HIV-1 Residual Viremia in Individuals Suppressed on Antiretroviral Therapy
Completed Study; data analyses ongoing
18-65 Years
NIAID
18
11-I-0007
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age with X-Linked Severe Combined Immunodeficiency
Participants currently recruited/enrolled
2-40 Years
NIAID
18
11-HG-0218
A Natural History Study of Patients with GNE Myopathy and GNE-Related Diseases
Participants currently recruited/enrolled
4-80 Years
NHGRI
18
11-HG-0110
Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
Enrolling by Invitation
18-120 Years
NHGRI
18
11-H-0046
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
11-EI-0264
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions
Completed Study; data analyses ongoing
18-125 Years
NEI
18
11-EI-0263
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions
Completed Study; data analyses ongoing
18-125 Years
NEI
18
11-EI-0245
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls
Participants currently recruited/enrolled
0-120 Years
NEI
18
11-EI-0147
Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration
No longer recruiting/follow-up only
50-100 Years
NEI
18
11-E-0006
The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection
Completed Study; data analyses ongoing
18-60 Years
NIEHS
18
11-DK-0168
Magnetic Resonance of Body, Arterial Wall, and Angiography Imaging for Non- Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using 1.5T and High Field (3T) MRI: A Technical Development Study of Cardiac a
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
11-DK-0151
Withdrawal of Therapy After Long-Term Oral Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
11-DK-0108
Observational Study of Persons with Hepatitis B Virus Infection in North America (Cohort Study)
Completed Study; data analyses ongoing
18-100 Years
NIDDK
18
11-CH-0078
Evaluation of Cortisol Resistance in Young Endurance-Trained and Elderly Men
Completed Study; data analyses ongoing
18-30 Years
NIDDK
18
11-CC-0152
The Natural History of Liver Disease in a Cohort of Participants with Hepatitis B and/or Hepatitis C with or without HIV Infection
Completed Study; data analyses ongoing
18-99 Years
CC
18
11-C-0247
A Randomized Phase II Study of Tecemotide in Combination with Standard Androgen Deprivation Therapy and Radiation Therapy for untreated, intermediate and High Risk Prostate Cancer Patients
Completed Study; data analyses ongoing
18-100 Years
NCI
18
11-C-0220
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Participants currently recruited/enrolled
18-125 Years
NCI
18
11-C-0161
A Phase I/II Study of the Mitogen Activated Protein Kinase Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; Hydrogen Sulfate in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
No longer recruiting/follow-up only
2-18 Years
NCI
18
11-C-0140
A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients with Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
11-C-0132
Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer
Completed Study; data analyses ongoing
18-99 Years
NCI
18
11-C-0123
A Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor-Infiltrating Lymphocytes Plus IL-2 Following Either a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Alone or in Conjunction with
No longer recruiting/follow-up only
18-66 Years
NCI
18
11-C-0112
Acquisition of Blood and Tumor Tissue Samples from Patients with Gastrointestinal Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
11-C-0096
Pilot Trial of Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
No longer recruiting/follow-up only
18-125 Years
NCI
18
11-C-0061
Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors
No longer recruiting/follow-up only
18-120 Years
NCI
18
11-C-0034
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Participants currently recruited/enrolled
0-125 Years
NCI
18
10-N-0143
A Prospective Natural History Study of Patients with Syringomyelia
No longer recruiting/follow-up only
18-125 Years
NINDS
18
10-N-0122
Evaluation, Pathogenesis, and Outcome of Subjects with or Suspected Traumatic Brain Injury
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
10-N-0009
Physiological Investigations of Movement Disorders
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
10-M-0112
Defining the Brain Phenotype of Children with 7q11.23 Copy Number Variation, Including Williams Syndrome and 7q11.23 Duplication Syndrome
Participants currently recruited/enrolled
5-125 Years
NIMH
18
10-M-0047
Top-Down Attentional Control of Visual-Processing
Participants currently recruited/enrolled
18-100 Years
NIMH
18
10-I-0216
Studies of Disorders with Increased Susceptibility to Fungal Infections
Participants currently recruited/enrolled
0-125 Years
NIAID
18
10-I-0139
Searching for Persistence of Infection in Lyme Disease
Completed Study; data analyses ongoing
18-125 Years
NIAID
18
10-I-0109
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Participants currently recruited/enrolled
18-125 Years
NIAID
18
10-HG-0076
Mothers' Thoughts about what their Children Eat
Completed Study; data analyses ongoing
18-100 Years
NHGRI
18
10-H-0141
A Phase II Study of Ofatumumab-Based Induction Chemoimmunotherapy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Completed Study; data analyses ongoing
18-99 Years
NHLBI
18
10-H-0083
A Phase I Trial of Safety and Immunogenicity of Gardasil Vaccination Post Stem Cell Transplantation in Patients with and without Immunosuppression
Completed Study; data analyses ongoing
18-50 Years
NHLBI
18
10-EI-0140
Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity
Participants currently recruited/enrolled
18-125 Years
NEI
18
10-E-0134
Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
Completed Study; data analyses ongoing
18-100 Years
NIEHS
18
10-E-0129
Study of the Effect of Innate Immunity on the Inflammatory Response to Endotoxin
Participants currently recruited/enrolled
18-100 Years
NIEHS
18
10-E-0063
Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing
Completed Study; data analyses ongoing
18-125 Years
NIEHS
18
10-DK-N091
Molecular and Clinical Profile of Diabetes Mellitus and its Complications
Participants currently recruited/enrolled
18-99 Years
NIDDK
18
10-DA-N457
Characterization of Phenotypic and Genotypic Regressors
Participants currently recruited/enrolled
18-125 Years
NIDA
18
10-CH-0198
Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging
Clinical hold/Recruitment or enrollment suspended
18-99 Years
NICHD
18
10-CC-0217
A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy
Completed Study; data analyses ongoing
18-125 Years
CC
18
10-CC-0150
Effects of Rapid-Resisted Exercise on Ambulatory Adults with Traumatic Brain Injury
Completed Study; data analyses ongoing
18-44 Years
CC
18
10-CC-0149
Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection
Completed Study; data analyses ongoing
18-80 Years
CC
18
10-CC-0118
Long Term Clinical Correlates of TBI: Imaging, Biomarkers, and Clinical Phenotyping Parameters
Clinical hold/Recruitment or enrollment suspended
18-125 Years
CC
18
10-CC-0115
Imaging Techniques in MRI
Participants currently recruited/enrolled
18-100 Years
CC
18
10-C-0201
Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells from Patients with DOCK8 Deficiency, LAD-1, and GATA2 Deficiency
Participants currently recruited/enrolled
18-40 Years
NCI
18
10-C-0166
A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab
Participants currently recruited/enrolled
18-72 Years
NCI
18
10-C-0114
A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
10-C-0066
A Study of Hairy Cell and other Leukemias with a Focus on Recombinant Immunotoxins for Cancer Treatment
Participants currently recruited/enrolled
18-125 Years
NCI
18
10-C-0056
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
18
10-C-0054
Administration of Anti-CD19-Chimeric-Antigen-Receptor-Transduced T Cells from the Original Transplant Donor to Patients with Recurrent or Persistent B-Cell Malignancies After Allogeneic Stem Cell Transplantation
Completed Study; data analyses ongoing
18-75 Years
NCI
18
10-C-0025
Randomized Phase II Trial of Rituximab with Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
No longer recruiting/follow-up only
18-125 Years
NCI
18
10-C-0011
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
18
10-AG-0423
A Pilot Study of Exendin-4 in Alzheimer's Disease
Completed Study; data analyses ongoing
60-125 Years
NIA
18
09-NR-0088
Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy
Completed Study; data analyses ongoing
18-125 Years
NINR
18
09-N-0039
A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated with Advanced Cancer
Participants currently recruited/enrolled
18-99 Years
NINDS
18
09-N-0010
Biomarkers of Risk of Parkinson Disease
Completed Study; data analyses ongoing
18-70 Years
NINDS
18
09-M-0176
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients with Schizophrenia: Characterization through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Participants currently recruited/enrolled
18-90 Years
NIMH
18
09-I-0200
A Phase I Study of MozobilTM in the Treatment of Patients with WHIMS
Participants currently recruited/enrolled
18-75 Years
NIAID
18
09-I-0133
Establishing Fibroblast-derived Cell Lines from Skin/Tissue Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders
Enrolling by Invitation
2-85 Years
NIAID
18
09-I-0030
Clinical and Immunologic Monitoring of Patients with Known or Suspected HIV Infection
Participants currently recruited/enrolled
18-125 Years
NIAID
18
09-I-0013
Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults
Completed Study; data analyses ongoing
18-100 Years
NIAID
18
09-H-0239
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization with the H1N1 or Seasonal Influenza Vaccines
Completed Study; data analyses ongoing
18-125 Years
NHLBI
18
09-H-0225
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
No longer recruiting/follow-up only
2-100 Years
NHLBI
18
09-DK-0223
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Participants currently recruited/enrolled
18-125 Years
NIDDK
18
09-DK-0097
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
Completed Study; data analyses ongoing
18-55 Years
NIDDK
18
09-CC-0217
Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteers
Completed Study; data analyses ongoing
18-55 Years
CC
18
09-C-0192
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
No longer recruiting/follow-up only
0-125 Years
NCI
18
09-C-0139
A Pilot Study of Vaccination with Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
18
09-C-0120
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
Completed Study; data analyses ongoing
18-125 Years
NCI
18
09-C-0024
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults
Completed Study; data analyses ongoing
12-26 Years
NCI
18
08-I-0221
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by Invitation
18-125 Years
NIAID
18
08-HG-0122
Patient-Provider Communication and Interaction in a Virtual Clinical Setting
Completed Study; data analyses ongoing
18-125 Years
NHGRI
18
08-H-0186
Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity with Bortezomib
Completed Study; data analyses ongoing
18-70 Years
NHLBI
18
08-H-0105
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Participants currently recruited/enrolled
18-110 Years
NHLBI
18
08-DK-N191
The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss
Participants currently recruited/enrolled
18-60 Years
NIDDK
18
08-DK-N140
Predicting Adaptive Thermogenesis
Completed Study; data analyses ongoing
18-60 Years
NIDDK
18
08-DK-0149
High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed after Standard Therapy
Completed Study; data analyses ongoing
18-65 Years
NIDDK
18
08-DK-0138
A New Method for Determining Gastric Acid Output Using a Wireless Capsule
Completed Study; data analyses ongoing
18-125 Years
NIDDK
18
08-DK-0004
High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
08-C-0214
A Pilot Study to Evaluate Neuropsychological Outcome Measures and their Relationship with Prognosis in Patients Receiving Radiation Therapy for Brain Metastases
Completed Study; data analyses ongoing
18-125 Years
NCI
18
08-C-0130
A Phase II Trial of Peginterferon alfa-2b (PEG-Intron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas
Completed Study; data analyses ongoing
0-21 Years
NCI
18
08-C-0020
A Phase II Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors
Completed Study; data analyses ongoing
18-120 Years
NCI
18
08-AG-0238
Development of Magnetic Resonance Imaging and Spectroscopy Research Methods for NIA Studies
Participants currently recruited/enrolled
18-125 Years
NIA
18
07-N-0190
Neurobiological Studies of Functional Movement Disorders and Non-Epileptic Seizures
Completed Study; data analyses ongoing
18-99 Years
NINDS
18
07-N-0122
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System
Completed Study; data analyses ongoing
18-125 Years
NINDS
18
07-M-0021
Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders
Participants currently recruited/enrolled
18-65 Years
NIMH
18
07-H-0142
Research Respiratory Tract Procedures
Participants currently recruited/enrolled
5-100 Years
NHLBI
18
07-H-0113
Procurement and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples from Healthy Volunteers to Support Clinical and Translational Research Projects in the NHLBI
Participants currently recruited/enrolled
8-99 Years
NHLBI
18
07-E-0023
Innate Immunity Signal Transduction in Human Leukocytes
Participants currently recruited/enrolled
18-65 Years
NIEHS
18
07-DK-N215
Study of Short-Term Metabolic Adaptation: Prediction of Weight Change and Effects of Macronutrient Manipulations
Completed Study; data analyses ongoing
18-55 Years
NIDDK
18
07-DK-0077
Study of the Phenotype of Overweight and Obese Adults
Participants currently recruited/enrolled
18-100 Years
NIDDK
18
07-CH-0008
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Completed Study; data analyses ongoing
18-85 Years
NIDDK
18
07-C-0195
Phase II Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using 8/8 and 7/8 HLA-matched Unrelated Donors and Utilizing Two Graft-versus-Host Disease Prophylaxis Regimens for the Trea
Completed Study; data analyses ongoing
18-74 Years
NCI
18
07-C-0121
Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal Cell Carcinoma (PRC)
Completed Study; data analyses ongoing
18-125 Years
NCI
18
06-I-0153
A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy
No longer recruiting/follow-up only
18-100 Years
NIAID
18
06-H-0217
Genetic Disorders of Mucociliary Clearance
Completed Study; data analyses ongoing
2-65 Years
NHLBI
18
06-H-0190
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)
Completed Study; data analyses ongoing
18-85 Years
NHLBI
18
06-H-0072
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Completed Study; data analyses ongoing
18-70 Years
NHLBI
18
06-EI-0068
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Completed Study; data analyses ongoing
18-125 Years
NEI
18
06-DA-N415
Screening Protocol for the Evaluation of Potential Research Subjects
Participants currently recruited/enrolled
18-100 Years
NIDA
18
06-C-0213
Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)
Participants currently recruited/enrolled
0-125 Years
NCI
18
06-C-0134
Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1
Completed Study; data analyses ongoing
20-99 Years
NCI
18
06-C-0014
Prospective Evaluation of Genetic and Epigenetic Alterations in Patients with Thoracic Malignancies
Participants currently recruited/enrolled
2-125 Years
NCI
18
06-AR-0198
A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Completed Study; data analyses ongoing
8-100 Years
NIAMS
18
05-I-0213
Screening and Baseline Assessment of Patients with Abnormalities of Immune Function
Participants currently recruited/enrolled
0-125 Years
NIAID
18
05-CH-0037
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag
Completed Study; data analyses ongoing
18-65 Years
NIDDK
18
05-CC-0216
Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation
Completed Study; data analyses ongoing
18-125 Years
CC
18
05-CC-0091
Electromagnetic Tracking of Devices During Interventional Procedures
Enrolling by Invitation
18-120 Years
CC
18
05-CC-0041
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets
Completed Study; data analyses ongoing
18-100 Years
CC
18
05-C-0252
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
18
04-N-0056
The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women with Endometriosis
Completed Study; data analyses ongoing
18-50 Years
NINDS
18
04-I-0266
Collection of Data and Samples from Healthy Donors for Use in Translational Research
Participants currently recruited/enrolled
18-85 Years
NIAID
18
04-H-0012
Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members
Participants currently recruited/enrolled
2-100 Years
NHLBI
18
04-C-0275
Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity
No longer recruiting/follow-up only
18-125 Years
NCI
18
04-C-0238
A Phase 2 Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
18
04-C-0200
Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence
Participants currently recruited/enrolled
18-125 Years
NCI
18
04-C-0165
Data Collection, Clinical Care and Interventions in CCR, NCI
Enrolling by Invitation
0-120 Years
NCI
18
04-AR-0205
Progression of Spinal Fusion in Ankylosing Spondylitis
Completed Study; data analyses ongoing
18-125 Years
NIAMS
18
03-I-0263
VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies
Participants currently recruited/enrolled
18-125 Years
NIAID
18
03-H-0170
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease (SCD) and B-Thalassemia
No longer recruiting/follow-up only
2-80 Years
NHLBI
18
03-DA-N380
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Participants currently recruited/enrolled
18-80 Years
NIDA
18
03-AR-0131
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Completed Study; data analyses ongoing
18-125 Years
NIAMS
18
02-I-0202
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral-Naive HIV-Infected Patients
Participants currently recruited/enrolled
18-120 Years
NIAID
18
02-I-0147
Genetic Studies of Chronic Active Epstein-Barr Virus Infection
Participants currently recruited/enrolled
1-120 Years
NIAID
18
02-I-0110
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients
Participants currently recruited/enrolled
3-100 Years
NIAID
18
02-I-0086
Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity
Participants currently recruited/enrolled
18-100 Years
NIAID
18
02-I-0055
Evaluation, Treatment, and Follow-up of Patients with Lyme Disease
Participants currently recruited/enrolled
2-99 Years
NIAID
18
02-H-0250
A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H
Completed Study; data analyses ongoing
18-100 Years
NHLBI
18
02-CC-0266
Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy
Completed Study; data analyses ongoing
18-100 Years
CC
18
02-C-0179
Biospecimen Acquisition from Human Subjects
Participants currently recruited/enrolled
18-125 Years
NCI
18
02-C-0178
Multidisciplinary Etiologic Study of Familial Testicular Cancer
No longer recruiting/follow-up only
12-125 Years
NCI
18
02-C-0064
Collection of Peripheral Blood and/or Urine From Patients Undergoing Radiation Therapy
Enrolling by Invitation
18-125 Years
NCI
18
01-N-0007
Evaluation, Pathogenesis, and Treatment of Patients with or at Risk for Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)
Participants currently recruited/enrolled
18-125 Years
NINDS
18
01-I-0238
Host Response to Infection and Treatment in Leishmania Infection of Humans
Participants currently recruited/enrolled
3-100 Years
NIAID
18
01-H-0122
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy
Participants currently recruited/enrolled
18-45 Years
NHLBI
18
01-H-0088
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia
Completed Study; data analyses ongoing
18-125 Years
NHLBI
18
01-C-0038
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
18
01-AR-0227
Studies of the Natural History of Rheumatic Disease in Minority Communities
Participants currently recruited/enrolled
18-100 Years
NIAMS
18
00-N-0082
Characterization of Brain Morphology and Activity Using Functional and Anatomical MRI Contrast
Participants currently recruited/enrolled
18-120 Years
NINDS
18
00-H-0051
Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis
Participants currently recruited/enrolled
18-90 Years
NHLBI
18
00-CH-0093
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma
Participants currently recruited/enrolled
3-120 Years
NICHD
18
99-DK-0002
Diabetes and Heart Disease Risk in Blacks
Participants currently recruited/enrolled
18-70 Years
NIDDK
18
99-C-0128
Evaluation for NCI Surgery Branch Clinical Research Protocols
Participants currently recruited/enrolled
18-125 Years
NCI
18
95-I-0027
Virologic and Immunologic Evaluation of Lymph Node, Tonsillar and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid
Participants currently recruited/enrolled
18-100 Years
NIAID
18
94-I-0079
Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans
Participants currently recruited/enrolled
1-100 Years
NIAID
18
94-E-0165
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
Participants currently recruited/enrolled
2-100 Years
NIEHS
18
93-I-0106
Cryptococcosis in Previously Healthy Adults
Participants currently recruited/enrolled
18-99 Years
NIAID
18
93-I-0086
Evaluation and Long-Term Follow-Up of Patients with Acute or Chronic Inflammatory Disorders
Enrolling by Invitation
2-125 Years
NIAID
18
93-I-0063
Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells
Participants currently recruited/enrolled
0-99 Years
NIAID
18
92-DK-0033
Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects
Completed Study; data analyses ongoing
18-35 Years
NIDDK
18
89-I-0158
Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes
Participants currently recruited/enrolled
2-120 Years
NIAID
18
88-I-0172
A Phase III Study with Long-Term Follow-Up of Zidovudine Versus Zidovudine and Alpha-Interferon Versus Alpha-Interferon in Patients with Early HIV Infection
No longer recruiting/follow-up only
18-125 Years
NIAID
18
83-C-0022
Psychological Benefits of a Normalized Camping Experience for Children with Cancer
Participants currently recruited/enrolled
7-25 Years
NCI
18
81-I-0164
Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies
Participants currently recruited/enrolled
18-100 Years
NIAID
18